≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Primary angle-closure glaucoma

DOID EFO Endpoint Browser PheWeb

H7_GLAUCCLOSEPRIM

primary angle closure glaucoma: The sudden increase of intraocular pressure, resulting in pain and an abrupt decrease in visual acuity.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H40.2
  • Hospital discharge: ICD-9 — 3652
  • Hospital discharge: ICD-8 — 37500|37511
  • Cause of death: ICD-10 — H40.2
  • Cause of death: ICD-9 — 3652
  • Cause of death: ICD-8 — 37500|37511

2 out of 7 registries used, show all original rules.

1766

4. Check minimum number of events

None

1766

5. Include endpoints

None

1766

6. Filter based on genotype QC (FinnGen only)

1702

Control definitions (FinnGen only)

Control exclude
H7_GLAUCOMA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H40
Name in latin
Glaucoma congestivum primarium

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 17902 11851 5834
Only index persons 13200 8791 4409
Unadjusted period prevalence (%)
Whole population 0.28 0.34 0.16
Only index persons 0.27 0.32 0.17
Median age at first event (years)
Whole population 68.78 69.73 66.90
Only index persons 67.76 68.71 65.87

-FinnGen-

Key figures

All Female Male
Number of individuals 1702 1000 702
Unadjusted period prevalence (%) 0.34 0.36 0.32
Median age at first event (years) 66.83 66.57 67.19

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1766
Matched controls
17660
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S01EC03
ATC
dorzolamide; ophthalmic
63.3
318.8
177
31
S01ED51
ATC
timolol, combinations; ophthalmic
84.9
307.7
1014
276
XCK00
NOMESCO Finland
Perimetry
22.1
307.7
473
288
CHC05
NOMESCO Finland
Iridotomy
743.9
307.7
808
20
114
Kela drug reimbursment
Glaucoma
94.4
307.7
1067
281
S01EC01
ATC
acetazolamide; systemic
49.9
307.7
296
71
H40.0
ICD-10 Finland
Glaucoma suspect
156.2
307.7
572
54
S01EX03, ,
ATC
64.2
307.7
244
44
S01EE05
ATC
tafluprost; ophthalmic
42.2
307.7
308
88
S01EE03
ATC
bimatoprost; ophthalmic
49.5
307.7
210
48
H40.20
ICD-10 Finland
Acute glaucoma with closed ventricular angle
+∞
307.7
644
*
H40.9
ICD-10 Finland
Glaucoma, unspecified
225.7
307.7
235
12
S01EC04
ATC
brinzolamide; ophthalmic
77.2
307.7
433
74
S01EA05
ATC
brimonidine; ophthalmic
195.9
307.7
321
20
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
307.4
307.7
385
16
S01EE01
ATC
latanoprost; ophthalmic
50.9
307.7
706
228
S01ED01
ATC
timolol; ophthalmic
45.9
307.7
441
127
S01EB01
ATC
pilocarpine; ophthalmic
150.3
307.7
246
19
H40.22
ICD-10 Finland
Chronic glaucoma with closed ventricular angle
16384.0
307.7
1017
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
27.3
292.8
204
84
S01EE04
ATC
travoprost; ophthalmic
37.0
267.5
168
50
Z96.1
ICD-10 Finland
Presence of intraocular lens
5.5
259.1
727
1996
S01EC54
ATC
brinzolamide, combinations; ophthalmic
114.9
250.6
128
12
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
569.9
208.5
203
*
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
28.6
206.1
140
53
S01EA03
ATC
apraclonidine; ophthalmic
33.8
196.2
126
40
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
364.3
194.6
193
6
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.4
186.1
449
1053
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
4.3
182.0
1209
5955
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.5
179.5
588
1761
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
5.6
178.6
396
860
S01ED02
ATC
betaxolol; ophthalmic
59.7
171.4
96
17
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
268.5
168.6
170
7
H40
ICD-10 Finland
Glaucoma
51.3
168.1
97
20
XCH00
NOMESCO Finland
Eye pressure measurement
8.0
165.8
242
343
CS494
NOMESCO Finland
Other visual field testing
17.3
161.7
136
85
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
21.5
154.8
117
58
H40.21
ICD-10 Finland
Intermittent glaucoma with closed ventricular angle
+∞
147.0
139
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
+∞
126.6
120
*
H40.11
ICD-10 Finland
Low pressure glaucoma
59.8
123.2
69
12
H40.29
ICD-10 Finland
Other [primary] glaucoma with closed ventricular angle
+∞
111.7
106
*
H25.1
ICD-10 Finland
Senile nuclear cataract
3.0
111.1
958
5006
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
6.8
104.8
172
274
XCK10
NOMESCO Finland
Photography of fundus of eye
4.0
100.5
328
945
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.8
96.9
946
5163
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
957.5
93.8
91
*
WX140
NOMESCO Finland
Parabulbar anesthesy
5.2
87.2
191
400
3652B
ICD-9 Finland
Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]
+∞
83.0
79
*
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.3
77.8
350
1233
S01BA07
ATC
fluorometholone; ophthalmic
10.2
77.1
88
90
CHD00
NOMESCO Finland
Laser trabeculoplasty
206.6
76.9
79
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
15.2
71.0
63
43
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
70.9
1014
6311
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.8
69.7
431
1808
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
+∞
65.0
62
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.0
64.3
195
526
F93
ICPC
Glaucoma
30.7
63.7
42
14
H26.4
ICD-10 Finland
After-cataract
2.8
62.2
379
1568
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
+∞
58.7
56
*
3652A
ICD-9 Finland
Glaucoma, Primary angle-closure glaucoma[AKUUTTI AHDASKULMAGLAUKOOMA]
+∞
57.6
55
*
XCH05
NOMESCO Finland
Eye pressure longterm registration
71.2
54.5
62
9
H40.8
ICD-10 Finland
Other glaucoma
533.4
52.8
52
*
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
64.2
48.5
56
9
37511
ICD-8 Finland
Glaucoma, Chronicum irritativum sive congestivum
+∞
43.9
42
*
ZXA10
NOMESCO Finland
Bilateral
2.2
42.6
440
2282
CHD99
NOMESCO Finland
Other filtering operation
+∞
41.8
40
*
37500
ICD-8 Finland
Glaucoma, Primary, acute
+∞
41.8
40
*
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
39.7
38
*
3651A
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]
+∞
38.7
37
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
5.9
37.1
68
120
SPAT1009
SPAT
Measurement of intraocular pressure
6.9
36.2
56
83
S01EA02
ATC
dipivefrine; ophthalmic
364.5
36.1
36
*
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
4.6
36.0
87
196
H40.2
ICD-10 Finland
Primary angle-closure glaucoma
+∞
35.5
34
*
CS2P4
NOMESCO Finland
Optic nerve head imaging
42.9
34.1
42
10
XCW10
NOMESCO Finland
Assessment of vision
7.0
34.0
52
76
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
6.5
32.2
53
84
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
5.9
32.0
58
101
H40.12
ICD-10 Finland
Pigmentary glaucoma
307.5
29.9
30
*
37510
ICD-8 Finland
Glaucoma, Chronicum simplex
+∞
29.2
28
*
S01BA01
ATC
dexamethasone; ophthalmic
3.6
29.2
101
296
H26.2
ICD-10 Finland
Complicated cataract
6.5
28.7
47
74
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
27.8
203
896
CHD35
NOMESCO Finland
Laser goniopuncture
+∞
27.1
26
*
S01FA01
ATC
atropine; ophthalmic
10.9
26.9
29
27
H57.1
ICD-10 Finland
Ocular pain
3.7
26.8
85
235
A10AA01, ,
ATC
4.7
26.5
62
136
CHC03
NOMESCO Finland
Laser iridoplasty
+∞
26.1
25
*
H3603, E103,
ICD-10 Finland
24.5
25.7
36
15
S01EE51
ATC
latanoprost and netarsudil; ophthalmic
94.8
25.7
28
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
9.3
25.7
31
34
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.8
25.3
79
216
S01BC03
ATC
diclofenac; ophthalmic
4.1
25.2
71
180
3708
FHL
Trabeculectomy or equivalent
+∞
25.1
24
*
ZXA05
NOMESCO Finland
Left side
1.8
24.8
526
3405
CK2P4
NOMESCO Finland
Optic nerve head light layer imaging (OCT)
56.8
24.1
28
5
CFW99
NOMESCO Finland
Other operation on conjunctiva
243.2
23.7
24
*
S01BA04
ATC
prednisolone; ophthalmic
4.0
23.2
66
169
H43.1
ICD-10 Finland
Vitreous haemorrhage
3.9
22.9
67
175
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
+∞
21.9
21
*
CHC00
NOMESCO Finland
Iridotomy
+∞
21.9
21
*
CKC15
NOMESCO Finland
Panretinal photocoagulation
6.4
21.9
36
57
H16.0
ICD-10 Finland
Corneal ulcer
2.9
21.2
100
354
F43
ICPC
Eye, Other diagnostic procedure
4.5
21.1
51
115
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
8.1
20.9
28
35
CKC12
NOMESCO Finland
Photocoagulation of retina
3.2
20.5
84
274
H34.8
ICD-10 Finland
Other retinal vascular occlusions
3.6
20.1
66
187
H40.19
ICD-10 Finland
Other primary glaucoma with open ventricular angle
+∞
19.8
19
*
WX142
NOMESCO Finland
Sub-tenon anesthesy
8.2
19.7
26
32
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
7.5
19.5
28
38
A10AB01
ATC
insulin (human); parenteral
3.3
19.1
72
223
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.4
18.9
132
569
H40.3
ICD-10 Finland
Glaucoma secondary to eye trauma
192.0
18.6
19
*
H26.02
ICD-10 Finland
Presenil cataract
3.6
18.5
61
173
H25.0
ICD-10 Finland
Senile incipient cataract
2.2
18.2
163
782
CHF15
NOMESCO Finland
Cryotherapy of ciliary body
+∞
17.7
17
*
CKD40
NOMESCO Finland
Endophotocoagulation of retina
4.7
17.6
40
86
CKC10
NOMESCO Finland
Local photocoagulation of retina
3.7
16.9
54
150
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
3.6
16.9
56
160
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
16.7
216
1185
3650A
ICD-9 Finland
Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]
+∞
16.7
16
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
13.5
16.5
28
21
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
4.6
16.1
38
84
ZXA00
NOMESCO Finland
Right side
1.6
15.9
521
3700
F38
ICPC
Eye, Other laboratory test NEC
3.9
14.8
43
112
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
11.4
14.8
27
24
CHD10
NOMESCO Finland
Trabeculectomy
+∞
14.6
14
*
CHB99
NOMESCO Finland
Other operation on anterior chamber and anterior chamber angle
151.2
14.5
15
*
E10
ICD-10 Finland
Type 1 diabetes mellitus
4.8
14.3
32
68
H40.1
ICD-10 Finland
Primary open-angle glaucoma
53.8
13.8
16
*
H04AA01
ATC
glucagon; nasal, parenteral
4.8
13.8
31
66
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
4.3
13.6
35
83
H25.8
ICD-10 Finland
Other senile cataract
1.7
13.6
286
1811
ZXC20
NOMESCO Finland
Use of chemical agents
3.2
13.6
53
168
37597
ICD-8 Finland
Glaucoma, Suspicio glaucomatis
+∞
13.6
13
*
CKD60
NOMESCO Finland
Anterior vitrectomy
4.8
13.3
30
64
H36.00
ICD-10 Finland
Diabetic background retinopathy
4.3
13.2
34
81
CS444, ,
SPAT
40.4
13.2
16
*
H52.0
ICD-10 Finland
Hypermetropia
3.4
13.1
46
137
A10AB04
ATC
insulin lispro; parenteral
3.1
13.0
54
178
A10AA02, ,
ATC
2.6
13.0
74
290
3661A
ICD-9 Finland
Cataract, Senile cataract
3.4
12.9
45
133
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
12.9
101
459
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
9.7
12.7
25
26
S01EX
ATC
Other antiglaucoma preparations
+∞
12.5
12
*
S01BC05
ATC
ketorolac; ophthalmic
2.2
12.4
105
492
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
11.7
12.3
22
19
H35.36
ICD-10 Finland
Macular cyst
5.4
12.3
24
45
A10AE06
ATC
insulin degludec; parenteral
2.7
12.0
63
237
T89
ICPC
Diabetes insulin dependent
2.7
12.0
64
243
S01FA04
ATC
cyclopentolate; ophthalmic
4.1
11.6
31
76
H3601, E103,
ICD-10 Finland
11.2
11.5
21
19
CA1ME
NOMESCO Finland
Ultrasound oculometry
5.1
11.5
24
48
37520
ICD-8 Finland
Glaucoma, Secondary
+∞
11.5
11
*
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
11.9
11.3
20
17
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
4.6
11.2
26
57
H44.5
ICD-10 Finland
Degenerated conditions of globe
43.6
10.9
13
*
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.6
10.5
60
236
Q15.0
ICD-10 Finland
Congenital glaucoma
+∞
10.4
10
*
3704
FHL
Iridectomy
+∞
10.4
10
*
A10AB05
ATC
insulin aspart; parenteral
1.9
10.4
142
792
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
2.4
10.3
71
306
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
23.5
10.2
14
6
H21.0
ICD-10 Finland
Hyphaema
13.2
10.2
17
13
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
3.1
10.1
40
129
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.9
10.0
125
678
CFB00
NOMESCO Finland
Suture of conjunctiva
55.3
9.7
11
*
H3603, E113,
ICD-10 Finland
4.5
9.6
23
52
CKD15
NOMESCO Finland
Injection of vitreous substitute
9.1
9.5
19
21
CKD20
NOMESCO Finland
Removal of vitreous body substitute
7.2
9.5
22
31
CJ2M4
NOMESCO Finland
Scans and measurement printouts for intraocular lens power calculation
3.9
9.4
27
70
TCG20
NOMESCO Finland
Laser suture lysis in cornea or sclera
+∞
9.4
9
*
E0000UV, ,
ATC
1.4
9.2
659
5324
A10AC01
ATC
insulin (human); parenteral
1.8
9.1
145
847
Z94.0
ICD-10 Finland
Kidney transplant status
4.6
9.1
21
46
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.6
8.9
52
207
ZXE00
NOMESCO Finland
One hour or less
1.4
8.7
606
4864
WX002
NOMESCO Finland
Sedation and analgesia
1.5
8.6
335
2428
127
Kela drug reimbursment
Transplant complication
3.8
8.5
25
66
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
3.5
8.5
29
85
CHC10
NOMESCO Finland
Peripheral iridectomy
90.5
8.4
9
*
TCA15
NOMESCO Finland
Retrobulbar therapeutic injection into orbit
+∞
8.3
8
*
3651B
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]
+∞
8.3
8
*
3711
FHL
Cyclodiateria or cryocoagulation
+∞
8.3
8
*
A10AE05
ATC
insulin detemir; parenteral
2.0
8.2
91
474
R42
ICD-10 Finland
Dizziness and giddiness
1.4
8.1
433
3320
171
Kela drug reimbursment
Degludekinsuliini
17.2
8.1
12
7
H27.1
ICD-10 Finland
Dislocation of lens
6.8
8.1
19
28
Z3231
NOMESCO Finland
Registered nurse
1.4
7.9
440
3393
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
6.4
7.7
19
30
137
Kela drug reimbursment
Uraemia requiring dialysis
4.4
7.7
19
44
H33.0
ICD-10 Finland
Retinal detachment with retinal break
2.3
7.6
54
236
S01FA02
ATC
scopolamine; ophthalmic
4.1
7.5
20
49
S18
ICPC
Laceration/cut
1.3
7.3
782
6644
3705
FHL
Iridectomy or iridotomy using a laser under general anesthesia
+∞
7.3
7
*
3656X
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]
+∞
7.3
7
*
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
+∞
7.3
7
*
3650B
ICD-9 Finland
Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AHDASKULMA)]
+∞
7.3
7
*
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
6.9
7.3
17
25
CKC20
NOMESCO Finland
Cryopexy of undetached retina
9.4
7.3
14
15
H54.0
ICD-10 Finland
Blindness, binocular
15.8
7.2
11
7
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
7.2
540
4359
H27.0
ICD-10 Finland
Aphakia
7.3
7.2
16
22
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
7.2
123
736
H31.4
ICD-10 Finland
Choroidal detachment
20.1
7.1
10
5
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
3.6
7.0
22
61
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
6.3
6.9
17
27
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.9
658
5489
H3600, E103,
ICD-10 Finland
5.9
6.9
18
31
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
6.9
1041
9242
F99
ICPC
Eye/adnexa disease other
4.0
6.9
19
48
H36.01
ICD-10 Finland
Diabetic maculopathy
3.2
6.9
26
82
XCD20
NOMESCO Finland
Photoangiography of eye
2.7
6.8
36
137
H54.4
ICD-10 Finland
Blindness, monocular
9.3
6.8
13
14
CWD00
NOMESCO Finland
Reoperation for superficial heamorrhage in eye and adjacent structures
40.2
6.8
8
*
F01
ICPC
Eye pain
2.4
6.7
44
186
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
2.6
6.7
38
150
CH2X4
NOMESCO Finland
Optical coherence tomography (OCT) of iris and iridocorneal angle
22.6
6.7
9
*
S01AD03
ATC
aciclovir; ophthalmic
2.1
6.7
61
297
Z94.7
ICD-10 Finland
Corneal transplant status
6.9
6.5
15
22
WZC30
NOMESCO Finland
Teaching
1.4
6.5
258
1873
WZC00, ,
SPAT
1.5
6.3
212
1490
H21.5
ICD-10 Finland
Other adhesions and disruptions of iris and ciliary body
+∞
6.3
6
*
S01EB02
ATC
carbachol; ophthalmic
+∞
6.3
6
*
3719
FHL
Other measure in this category
+∞
6.3
6
*
XCH05, ,
SPAT
26.8
6.2
8
*
L04AA06
ATC
mycophenolic acid; systemic
2.9
6.2
28
98
CK2M4
NOMESCO Finland
Macular light layer imaging (OCT)
3.7
6.2
19
52
B05DA
ATC
Isotonic solutions
5.0
6.2
18
36
H25.2
ICD-10 Finland
Senile cataract, morgagnian type
5.0
6.2
18
36
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
6.3
6.2
15
24

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Ophthalmology
18 [38004463]
8.2e-01
1.8e+00
2.9e+00
3.6e+01
4.5e+00
3.5e+00
2.2e+00
cases:28.44%
controls:14.94%
cases:26.36%
controls:5.78%
cases:14.22%
controls:0.92%
cases:95.66%
controls:0.03%
cases:45.40%
controls:0.95%
cases:69.33%
controls:6.15%
cases:66.98%
controls:18.67%
492
2577
1238
14676
456
997
1274
16256
246
158
1484
17095
1655
6
75
17247
785
164
944
17067
1173
1037
519
15831
992
2708
489
11795
timolol, combinations
S01ED51 [21603705]
3.6e+00
4.1e+00
4.9e+00
1.0e+50
5.3e+00
5.2e+00
4.6e+00
cases:12.95%
controls:0.39%
cases:16.76%
controls:0.32%
cases:10.23%
controls:0.08%
cases:9.25%
controls:0.00%
cases:21.23%
controls:0.13%
cases:36.82%
controls:0.32%
cases:38.69%
controls:0.61%
224
68
1506
17185
290
55
1440
17198
177
14
1553
17239
160
0
1570
17253
367
23
1362
17208
623
54
1069
16814
573
89
908
14414
timolol
S01ED01 [21603699]
3.7e+00
4.2e+00
4.4e+00
—
5.3e+00
4.9e+00
4.6e+00
cases:12.37%
controls:0.36%
cases:13.82%
controls:0.25%
cases:6.88%
controls:0.09%
—
—
cases:12.32%
controls:0.07%
cases:24.88%
controls:0.24%
cases:30.52%
controls:0.46%
214
62
1516
17191
239
43
1491
17210
119
16
1611
17237
—
213
12
1516
17219
421
41
1271
16827
452
67
1029
14436
latanoprost
S01EE01 [21603710]
3.6e+00
4.1e+00
4.8e+00
1.0e+50
5.1e+00
4.9e+00
4.3e+00
cases:11.04%
controls:0.34%
cases:14.05%
controls:0.27%
cases:6.94%
controls:0.06%
cases:4.74%
controls:0.00%
cases:11.16%
controls:0.08%
cases:25.41%
controls:0.25%
cases:27.55%
controls:0.51%
191
59
1539
17194
243
46
1487
17207
120
11
1610
17242
82
0
1648
17253
193
13
1536
17218
430
42
1262
16826
408
74
1073
14429
tafluprost
S01EE05 [21603714]
3.5e+00
4.0e+00
4.4e+00
—
4.9e+00
4.6e+00
4.3e+00
cases:4.10%
controls:0.13%
cases:6.01%
controls:0.12%
cases:2.83%
controls:0.03%
—
—
cases:4.68%
controls:0.03%
cases:10.40%
controls:0.12%
cases:11.61%
controls:0.17%
71
22
1659
17231
104
20
1626
17233
49
6
1681
17247
—
81
6
1648
17225
176
20
1516
16848
172
25
1309
14478
dorzolamide
S01EC03 [21603695]
3.6e+00
4.3e+00
—
1.0e+50
5.6e+00
5.4e+00
4.2e+00
cases:5.20%
controls:0.16%
cases:6.13%
controls:0.09%
—
—
cases:4.80%
controls:0.00%
cases:11.51%
controls:0.05%
cases:16.02%
controls:0.09%
cases:15.87%
controls:0.29%
90
27
1640
17226
106
15
1624
17238
—
83
0
1647
17253
199
8
1530
17223
271
15
1421
16853
235
42
1246
14461
travoprost
S01EE04 [21603713]
3.3e+00
3.6e+00
3.3e+00
1.0e+50
4.5e+00
4.1e+00
3.8e+00
cases:3.18%
controls:0.12%
cases:3.47%
controls:0.10%
cases:1.10%
controls:0.04%
cases:0.87%
controls:0.00%
cases:2.43%
controls:0.03%
cases:5.26%
controls:0.09%
cases:6.28%
controls:0.15%
55
21
1675
17232
60
17
1670
17236
19
7
1711
17246
15
0
1715
17253
42
5
1687
17226
89
16
1603
16852
93
22
1388
14481
brinzolamide
S01EC04 [21603696]
3.6e+00
4.0e+00
—
1.0e+50
4.3e+00
4.9e+00
4.7e+00
cases:4.86%
controls:0.13%
cases:5.66%
controls:0.11%
—
—
cases:2.14%
controls:0.00%
cases:4.40%
controls:0.06%
cases:11.52%
controls:0.10%
cases:15.33%
controls:0.16%
84
23
1646
17230
98
19
1632
17234
—
37
0
1693
17253
76
11
1653
17220
195
17
1497
16851
227
23
1254
14480
brinzolamide, combinations
S01EC54 [45893490]
3.6e+00
4.0e+00
—
1.0e+50
4.4e+00
4.7e+00
4.7e+00
cases:5.43%
controls:0.16%
cases:6.24%
controls:0.12%
—
—
cases:2.66%
controls:0.00%
cases:5.84%
controls:0.08%
cases:13.36%
controls:0.14%
cases:17.35%
controls:0.19%
94
27
1636
17226
108
21
1622
17232
—
46
0
1684
17253
101
13
1628
17218
226
23
1466
16845
257
27
1224
14476
Glaucoma
114 [2001600114]
3.6e+00
4.7e+00
—
1.0e+50
—
5.7e+00
3.4e+00
cases:7.69%
controls:0.22%
cases:5.32%
controls:0.05%
—
—
cases:0.40%
controls:0.00%
—
—
cases:13.95%
controls:0.05%
cases:6.68%
controls:0.23%
133
38
1597
17215
92
9
1638
17244
—
7
0
1723
17253
—
236
9
1456
16859
99
34
1382
14469
bimatoprost
S01EE03 [21603712]
3.4e+00
4.0e+00
—
1.0e+50
—
4.7e+00
4.4e+00
cases:2.83%
controls:0.10%
cases:3.53%
controls:0.07%
—
—
cases:0.98%
controls:0.00%
—
—
cases:7.27%
controls:0.07%
cases:9.05%
controls:0.12%
49
17
1681
17236
61
12
1669
17241
—
17
0
1713
17253
—
123
12
1569
16856
134
18
1347
14485
Glaucoma
H40 [45547879]
3.6e+00
4.2e+00
—
1.0e+50
1.0e+50
5.2e+00
3.2e+00
cases:4.28%
controls:0.13%
cases:2.72%
controls:0.04%
—
—
cases:0.29%
controls:0.00%
cases:3.88%
controls:0.00%
cases:8.10%
controls:0.05%
cases:4.73%
controls:0.19%
74
22
1656
17231
47
7
1683
17246
—
5
0
1725
17253
67
0
1662
17231
137
8
1555
16860
70
28
1411
14475
prednisolone
S01BA04 [21603621]
6.1e-01
1.7e+00
3.1e+00
1.0e+50
4.4e+00
3.0e+00
1.6e+00
cases:2.77%
controls:1.52%
cases:2.95%
controls:0.56%
cases:1.85%
controls:0.08%
cases:4.91%
controls:0.00%
cases:5.90%
controls:0.08%
cases:9.16%
controls:0.50%
cases:8.44%
controls:1.92%
48
263
1682
16990
51
97
1679
17156
32
14
1698
17239
85
0
1645
17253
102
13
1627
17218
155
85
1537
16783
125
278
1356
14225
prednisolone
S03BA02 [21605202]
6.1e-01
1.7e+00
3.1e+00
1.0e+50
4.4e+00
3.0e+00
1.6e+00
cases:2.77%
controls:1.52%
cases:2.95%
controls:0.56%
cases:1.85%
controls:0.08%
cases:4.91%
controls:0.00%
cases:5.90%
controls:0.08%
cases:9.16%
controls:0.50%
cases:8.44%
controls:1.92%
48
263
1682
16990
51
97
1679
17156
32
14
1698
17239
85
0
1645
17253
102
13
1627
17218
155
85
1537
16783
125
278
1356
14225
Other investigative procedure of eye
XCW99 [2001301491]
1.4e+00
1.6e+00
2.2e+00
1.0e+50
3.7e+00
2.7e+00
2.0e+00
cases:3.93%
controls:1.03%
cases:1.97%
controls:0.42%
cases:0.75%
controls:0.08%
cases:2.77%
controls:0.00%
cases:1.68%
controls:0.04%
cases:6.97%
controls:0.49%
cases:8.24%
controls:1.15%
68
177
1662
17076
34
73
1696
17180
13
14
1717
17239
48
0
1682
17253
29
7
1700
17224
118
82
1574
16786
122
167
1359
14336
Perimetry
XCK00 [2001301380]
2.4e+00
3.3e+00
—
1.0e+50
1.0e+50
4.1e+00
3.7e+00
cases:4.34%
controls:0.39%
cases:2.37%
controls:0.09%
—
—
cases:3.70%
controls:0.00%
cases:1.16%
controls:0.00%
cases:8.27%
controls:0.15%
cases:10.53%
controls:0.29%
75
68
1655
17185
41
16
1689
17237
—
64
0
1666
17253
20
0
1709
17231
140
25
1552
16843
156
42
1325
14461
Examination of eyes and vision
Z01.0 [45566391]
9.8e-01
1.7e+00
3.0e+00
—
3.8e+00
2.6e+00
1.5e+00
cases:4.34%
controls:1.67%
cases:3.53%
controls:0.64%
cases:1.45%
controls:0.08%
—
—
cases:2.95%
controls:0.07%
cases:7.80%
controls:0.64%
cases:8.91%
controls:2.21%
75
288
1655
16965
61
111
1669
17142
25
13
1705
17240
—
51
12
1678
17219
132
108
1560
16760
132
320
1349
14183
acetazolamide; oral, parenteral
S01EC01 [21603693]
3.7e+00
—
—
1.0e+50
—
4.8e+00
4.7e+00
cases:2.31%
controls:0.06%
—
—
—
—
cases:1.33%
controls:0.00%
—
—
cases:3.96%
controls:0.04%
cases:4.46%
controls:0.04%
40
10
1690
17243
—
—
23
0
1707
17253
—
67
6
1625
16862
66
6
1415
14497
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
1.2e+00
1.4e+00
2.1e+00
—
3.4e+00
2.5e+00
1.7e+00
cases:2.37%
controls:0.75%
cases:1.45%
controls:0.36%
cases:0.52%
controls:0.06%
—
—
cases:1.04%
controls:0.03%
cases:4.49%
controls:0.40%
cases:6.62%
controls:1.32%
41
130
1689
17123
25
62
1705
17191
9
11
1721
17242
—
18
6
1711
17225
76
67
1616
16801
98
192
1383
14311
dexamethasone
S03BA01 [21605201]
6.8e-01
1.4e+00
2.4e+00
1.0e+50
4.0e+00
2.3e+00
1.3e+00
cases:4.16%
controls:2.16%
cases:2.43%
controls:0.64%
cases:1.16%
controls:0.11%
cases:5.03%
controls:0.00%
cases:6.19%
controls:0.12%
cases:7.27%
controls:0.78%
cases:9.86%
controls:2.91%
72
373
1658
16880
42
110
1688
17143
20
19
1710
17234
87
0
1643
17253
107
20
1622
17211
123
132
1569
16736
146
422
1335
14081
dexamethasone
S01BA01 [21603618]
6.8e-01
1.4e+00
2.4e+00
1.0e+50
4.0e+00
2.3e+00
1.3e+00
cases:4.16%
controls:2.16%
cases:2.43%
controls:0.64%
cases:1.16%
controls:0.11%
cases:5.03%
controls:0.00%
cases:6.19%
controls:0.12%
cases:7.27%
controls:0.78%
cases:9.86%
controls:2.91%
72
373
1658
16880
42
110
1688
17143
20
19
1710
17234
87
0
1643
17253
107
20
1622
17211
123
132
1569
16736
146
422
1335
14081
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
1.5e+00
1.7e+00
2.3e+00
—
2.2e+00
1.8e+00
1.7e+00
cases:1.73%
controls:0.39%
cases:1.33%
controls:0.24%
cases:0.52%
controls:0.05%
—
—
cases:0.46%
controls:0.05%
cases:1.42%
controls:0.24%
cases:2.50%
controls:0.48%
30
68
1700
17185
23
41
1707
17212
9
9
1721
17244
—
8
9
1721
17222
24
40
1668
16828
37
70
1444
14433
Presence of intraocular lens
Z96.1 [45585885]
2.1e-01
5.6e-01
2.0e+00
1.0e+50
3.8e+00
3.0e+00
2.1e+00
cases:1.97%
controls:1.61%
cases:1.39%
controls:0.80%
cases:0.87%
controls:0.12%
cases:2.77%
controls:0.00%
cases:2.26%
controls:0.05%
cases:12.59%
controls:0.69%
cases:18.64%
controls:2.85%
34
277
1696
16976
24
138
1706
17115
15
21
1715
17232
48
0
1682
17253
39
9
1690
17222
213
117
1479
16751
276
414
1205
14089
Outpatient Visit
OP [9202]
2.9e-01
4.7e-01
7.3e-01
5.1e+00
1.8e+00
1.1e+00
1.0e+00
cases:72.20%
controls:66.09%
cases:59.31%
controls:47.72%
cases:18.67%
controls:9.97%
cases:42.25%
controls:0.44%
cases:40.54%
controls:9.69%
cases:74.76%
controls:48.49%
cases:89.20%
controls:74.54%
1249
11402
481
5851
1026
8233
704
9020
323
1720
1407
15533
731
76
999
17177
701
1670
1028
15561
1265
8180
427
8688
1321
10810
160
3693
Photography of fundus of eye
XCK10 [2001301381]
7.4e-01
9.1e-01
2.3e+00
1.0e+50
3.0e+00
2.3e+00
1.4e+00
cases:3.58%
controls:1.74%
cases:1.56%
controls:0.63%
cases:0.35%
controls:0.03%
cases:1.50%
controls:0.00%
cases:1.10%
controls:0.06%
cases:4.43%
controls:0.47%
cases:5.81%
controls:1.54%
62
300
1668
16953
27
109
1703
17144
6
6
1724
17247
26
0
1704
17253
19
10
1710
17221
75
79
1617
16789
86
223
1395
14280
Eye pressure measurement
XCH00 [2001301234]
1.7e+00
2.5e+00
—
1.0e+50
—
3.8e+00
2.4e+00
cases:1.33%
controls:0.26%
cases:0.87%
controls:0.07%
—
—
cases:1.39%
controls:0.00%
—
—
cases:5.02%
controls:0.11%
cases:5.00%
controls:0.48%
23
44
1707
17209
15
12
1715
17241
—
24
0
1706
17253
—
85
19
1607
16849
74
70
1407
14433
Emergency Room Visit
ER [9203]
1.6e-01
2.6e-01
1.3e+00
6.0e+00
1.7e+00
5.8e-01
4.3e-01
cases:33.99%
controls:30.58%
cases:14.68%
controls:11.68%
cases:5.61%
controls:1.61%
cases:24.28%
controls:0.08%
cases:6.77%
controls:1.33%
cases:18.32%
controls:11.15%
cases:40.18%
controls:30.40%
588
5276
1142
11977
254
2015
1476
15238
97
277
1633
16976
420
14
1310
17239
117
229
1612
17002
310
1880
1382
14988
595
4409
886
10094
fluorometholone
S01BA07 [21603624]
1.8e+00
2.8e+00
—
—
—
3.2e+00
2.2e+00
cases:2.49%
controls:0.41%
cases:2.14%
controls:0.14%
—
—
—
—
—
—
cases:4.08%
controls:0.17%
cases:4.39%
controls:0.50%
43
70
1687
17183
37
24
1693
17229
—
—
—
69
28
1623
16840
65
72
1416
14431
Senile nuclear cataract
H25.1 [45581628]
-3.6e-01
7.3e-01
2.4e+00
1.0e+50
3.2e+00
2.4e+00
1.3e+00
cases:3.35%
controls:4.74%
cases:3.35%
controls:1.64%
cases:2.02%
controls:0.19%
cases:6.01%
controls:0.00%
cases:4.92%
controls:0.21%
cases:14.89%
controls:1.55%
cases:19.85%
controls:6.47%
58
818
1672
16435
58
283
1672
16970
35
33
1695
17220
104
0
1626
17253
85
36
1644
17195
252
262
1440
16606
294
939
1187
13564
Glaucoma suspect
H40.0 [45567051]
—
5.3e+00
—
1.0e+50
1.0e+50
—
4.6e+00
—
—
cases:7.46%
controls:0.04%
—
—
cases:5.26%
controls:0.00%
cases:3.35%
controls:0.00%
—
—
cases:8.58%
controls:0.09%
—
129
7
1601
17246
—
91
0
1639
17253
58
0
1671
17231
—
127
13
1354
14490
Proliferative diabetic retinopathy and Type 1 diabetes mellitus, With ophthalmic complications
H36.03*E10.3 [2000503982]
2.4e+00
2.5e+00
—
1.0e+50
—
2.6e+00
2.4e+00
cases:1.04%
controls:0.10%
cases:0.69%
controls:0.06%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.83%
controls:0.06%
cases:1.15%
controls:0.10%
18
17
1712
17236
12
10
1718
17243
—
7
0
1723
17253
—
14
10
1678
16858
17
15
1464
14488
antibiotics in combination with other drugs
S01AA20 [21603571]
8.5e-02
9.3e-01
2.3e+00
1.0e+50
3.0e+00
2.0e+00
1.1e+00
cases:8.38%
controls:7.75%
cases:5.43%
controls:2.21%
cases:2.77%
controls:0.27%
cases:0.98%
controls:0.00%
cases:6.02%
controls:0.31%
cases:16.02%
controls:2.40%
cases:23.57%
controls:8.92%
145
1337
1585
15916
94
381
1636
16872
48
47
1682
17206
17
0
1713
17253
104
54
1625
17177
271
405
1421
16463
349
1293
1132
13210
Acute and subacute iridocyclitis
H20.0 [45542994]
1.4e+00
2.2e+00
—
1.0e+50
—
3.4e+00
2.5e+00
cases:1.10%
controls:0.27%
cases:0.75%
controls:0.09%
—
—
cases:0.75%
controls:0.00%
—
—
cases:3.01%
controls:0.11%
cases:4.12%
controls:0.34%
19
47
1711
17206
13
15
1717
17238
—
13
0
1717
17253
—
51
18
1641
16850
61
49
1420
14454
Phakoemulsification with implantation of artificial lens in posterior chamber
CJE20 [2001301342]
-3.1e-01
2.9e-01
2.0e+00
1.0e+50
3.2e+00
2.7e+00
1.2e+00
cases:3.99%
controls:5.37%
cases:2.20%
controls:1.65%
cases:0.87%
controls:0.12%
cases:1.91%
controls:0.00%
cases:4.28%
controls:0.17%
cases:18.85%
controls:1.58%
cases:21.00%
controls:7.29%
69
926
1661
16327
38
285
1692
16968
15
20
1715
17233
33
0
1697
17253
74
30
1655
17201
319
266
1373
16602
311
1057
1170
13446
Insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E10.2 [2000503132]
2.0e+00
2.4e+00
—
—
—
2.3e+00
2.3e+00
cases:0.58%
controls:0.08%
cases:0.64%
controls:0.06%
—
—
—
—
—
—
cases:0.53%
controls:0.05%
cases:0.74%
controls:0.08%
10
13
1720
17240
11
10
1719
17243
—
—
—
9
9
1683
16859
11
11
1470
14492
Visual field testing with Octopus automated perimetry
CS444 [2001301477]
2.9e+00
2.2e+00
—
1.0e+50
—
—
3.8e+00
cases:1.45%
controls:0.08%
cases:0.52%
controls:0.06%
—
—
cases:1.50%
controls:0.00%
—
—
—
—
cases:4.12%
controls:0.10%
25
14
1705
17239
9
10
1721
17243
—
26
0
1704
17253
—
—
61
14
1420
14489
levofloxacin
S01AE05 [43534860]
-2.8e-01
5.5e-01
1.8e+00
1.0e+50
3.6e+00
2.4e+00
1.0e+00
cases:1.45%
controls:1.90%
cases:1.27%
controls:0.74%
cases:0.52%
controls:0.09%
cases:0.52%
controls:0.00%
cases:2.31%
controls:0.06%
cases:7.68%
controls:0.75%
cases:7.56%
controls:2.93%
25
328
1705
16925
22
127
1708
17126
9
15
1721
17238
9
0
1721
17253
40
11
1689
17220
130
127
1562
16741
112
425
1369
14078
pilocarpine, combinations
S01EB51 [21603690]
3.9e+00
—
1.0e+50
1.0e+50
—
4.7e+00
—
cases:1.73%
controls:0.03%
—
—
cases:1.33%
controls:0.00%
cases:0.52%
controls:0.00%
—
—
cases:3.84%
controls:0.04%
—
—
30
6
1700
17247
—
23
0
1707
17253
9
0
1721
17253
—
65
6
1627
16862
—
Other retinal vascular occlusions
H34.8 [45547863]
1.1e+00
1.6e+00
2.5e+00
—
—
2.4e+00
2.0e+00
cases:0.69%
controls:0.23%
cases:0.52%
controls:0.11%
cases:0.40%
controls:0.03%
—
—
—
—
cases:1.30%
controls:0.12%
cases:2.03%
controls:0.28%
12
40
1718
17213
9
19
1721
17234
7
6
1723
17247
—
—
22
20
1670
16848
30
40
1451
14463
T1D - yes
T1D-1 [2002330228]
2.6e+00
—
—
—
—
2.9e+00
2.8e+00
cases:0.46%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.03%
cases:0.54%
controls:0.03%
8
6
1722
17247
—
—
—
—
9
5
1683
16863
8
5
1473
14498
Conjunctival surface anesthesia
WX100 [2001310764]
-1.4e-01
4.6e-01
—
1.0e+50
3.8e+00
2.9e+00
1.3e+00
cases:1.27%
controls:1.45%
cases:0.69%
controls:0.44%
—
—
cases:0.75%
controls:0.00%
cases:2.20%
controls:0.05%
cases:7.68%
controls:0.46%
cases:6.95%
controls:1.98%
22
251
1708
17002
12
76
1718
17177
—
13
0
1717
17253
38
9
1691
17222
130
78
1562
16790
103
287
1378
14216
Inpatient Hospital
21 [8717]
2.1e-01
2.2e-01
7.1e-01
5.1e+00
1.3e+00
3.0e-01
2.9e-01
cases:37.11%
controls:32.35%
cases:14.86%
controls:12.29%
cases:3.70%
controls:1.85%
cases:14.68%
controls:0.11%
cases:5.96%
controls:1.66%
cases:15.19%
controls:11.74%
cases:35.18%
controls:28.80%
642
5581
1088
11672
257
2120
1473
15133
64
320
1666
16933
254
19
1476
17234
103
286
1626
16945
257
1980
1435
14888
521
4177
960
10326
hypromellose
S01KA02 [21605115]
8.5e-01
1.2e+00
1.7e+00
—
1.3e+00
1.6e+00
1.3e+00
cases:5.26%
controls:2.32%
cases:3.41%
controls:1.09%
cases:0.92%
controls:0.17%
—
—
cases:0.81%
controls:0.21%
cases:4.73%
controls:1.02%
cases:8.98%
controls:2.67%
91
401
1639
16852
59
188
1671
17065
16
30
1714
17223
—
14
37
1715
17194
80
172
1612
16696
133
387
1348
14116
Other senile cataract
H25.8 [45605644]
-3.9e-01
6.6e-01
1.8e+00
1.0e+50
3.1e+00
2.0e+00
1.0e+00
cases:1.04%
controls:1.52%
cases:1.16%
controls:0.60%
cases:0.40%
controls:0.07%
cases:1.33%
controls:0.00%
cases:1.27%
controls:0.06%
cases:4.31%
controls:0.62%
cases:5.94%
controls:2.24%
18
263
1712
16990
20
104
1710
17149
7
12
1723
17241
23
0
1707
17253
22
10
1707
17221
73
104
1619
16764
88
325
1393
14178
Left side
ZXA05 [2001311347]
3.6e-01
6.7e-01
2.2e+00
—
2.5e+00
1.7e+00
7.5e-01
cases:5.26%
controls:3.74%
cases:1.97%
controls:1.01%
cases:0.81%
controls:0.09%
—
—
cases:1.39%
controls:0.11%
cases:5.44%
controls:1.04%
cases:7.09%
controls:3.48%
91
645
1639
16608
34
175
1696
17078
14
16
1716
17237
—
24
19
1705
17212
92
175
1600
16693
105
505
1376
13998
Parabulbar anesthesia
WX140 [2001310772]
5.1e-01
2.2e+00
—
1.0e+50
—
3.4e+00
2.1e+00
cases:0.58%
controls:0.35%
cases:0.81%
controls:0.09%
—
—
cases:0.40%
controls:0.00%
—
—
cases:2.96%
controls:0.11%
cases:2.97%
controls:0.37%
10
60
1720
17193
14
15
1716
17238
—
7
0
1723
17253
—
50
18
1642
16850
44
53
1437
14450
Pars plana or pars plicata vitrectomy
CKD65 [2001301417]
1.3e+00
3.2e+00
—
1.0e+50
1.0e+50
2.6e+00
1.7e+00
cases:0.58%
controls:0.16%
cases:0.69%
controls:0.03%
—
—
cases:0.35%
controls:0.00%
cases:0.46%
controls:0.00%
cases:0.83%
controls:0.06%
cases:1.35%
controls:0.25%
10
28
1720
17225
12
5
1718
17248
—
6
0
1724
17253
8
0
1721
17231
14
10
1678
16858
20
36
1461
14467
Right side
ZXA00 [2001311346]
3.8e-01
6.9e-01
1.7e+00
1.0e+50
2.7e+00
1.6e+00
8.7e-01
cases:5.32%
controls:3.72%
cases:2.02%
controls:1.02%
cases:0.58%
controls:0.11%
cases:1.04%
controls:0.00%
cases:1.45%
controls:0.10%
cases:4.73%
controls:1.00%
cases:8.31%
controls:3.66%
92
641
1638
16612
35
176
1695
17077
10
19
1720
17234
18
0
1712
17253
25
17
1704
17214
80
168
1612
16700
123
531
1358
13972
Outpatient Hospital
22 [8756]
1.9e-01
2.4e-01
9.5e-01
3.9e+00
1.6e+00
3.5e-01
4.0e-01
cases:28.96%
controls:25.29%
cases:10.35%
controls:8.34%
cases:2.66%
controls:1.04%
cases:3.99%
controls:0.08%
cases:4.57%
controls:0.96%
cases:10.46%
controls:7.60%
cases:28.76%
controls:21.31%
501
4364
1229
12889
179
1439
1551
15814
46
180
1684
17073
69
14
1661
17239
79
165
1650
17066
177
1282
1515
15586
426
3091
1055
11412
Proliferative diabetic retinopathy
H36.03 [2000502323]
2.1e+00
2.6e+00
—
—
—
—
2.2e+00
cases:0.64%
controls:0.08%
cases:0.40%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.09%
11
13
1719
17240
7
5
1723
17248
—
—
—
—
12
13
1469
14490
Vitreous haemorrhage
H43.1 [45543053]
1.6e+00
1.9e+00
—
—
—
2.2e+00
1.3e+00
cases:0.92%
controls:0.20%
cases:0.64%
controls:0.10%
—
—
—
—
—
—
cases:0.89%
controls:0.10%
cases:1.08%
controls:0.28%
16
34
1714
17219
11
17
1719
17236
—
—
—
15
17
1677
16851
16
41
1465
14462
Chronic iridocyclitis
H20.1 [45562191]
—
—
—
1.0e+50
—
3.6e+00
3.2e+00
—
—
—
—
—
—
cases:0.35%
controls:0.00%
—
—
cases:1.06%
controls:0.03%
cases:1.62%
controls:0.07%
—
—
—
6
0
1724
17253
—
18
5
1674
16863
24
10
1457
14493
Bilateral
ZXA10 [2001311348]
2.7e-01
7.8e-01
—
1.0e+50
2.7e+00
2.1e+00
9.9e-01
cases:3.06%
controls:2.36%
cases:1.45%
controls:0.67%
—
—
cases:2.54%
controls:0.00%
cases:0.93%
controls:0.06%
cases:4.31%
controls:0.58%
cases:6.14%
controls:2.39%
53
407
1677
16846
25
115
1705
17138
—
44
0
1686
17253
16
11
1713
17220
73
97
1619
16771
91
346
1390
14157
Plain photography of ocular fundus
CK2S4 [2001301455]
5.6e-01
1.0e+00
—
1.0e+50
2.8e+00
1.9e+00
1.7e+00
cases:0.81%
controls:0.46%
cases:0.46%
controls:0.17%
—
—
cases:0.64%
controls:0.00%
cases:0.64%
controls:0.04%
cases:1.83%
controls:0.27%
cases:3.65%
controls:0.66%
14
80
1716
17173
8
29
1722
17224
—
11
0
1719
17253
11
7
1718
17224
31
45
1661
16823
54
95
1427
14408
dexamethasone; local oral
A01AC02 [21600035]
2.4e-01
1.1e+00
—
—
2.8e+00
1.4e+00
9.1e-01
cases:1.45%
controls:1.14%
cases:0.81%
controls:0.28%
—
—
—
—
cases:0.87%
controls:0.05%
cases:1.89%
controls:0.47%
cases:3.71%
controls:1.52%
25
197
1705
17056
14
49
1716
17204
—
—
15
9
1714
17222
32
79
1660
16789
55
221
1426
14282
tropicamide
S01FA06 [21605065]
1.7e+00
—
—
—
1.0e+50
2.6e+00
1.9e+00
cases:0.58%
controls:0.10%
—
—
—
—
—
—
cases:0.40%
controls:0.00%
cases:0.47%
controls:0.04%
cases:1.15%
controls:0.18%
10
18
1720
17235
—
—
—
7
0
1722
17231
8
6
1684
16862
17
26
1464
14477
Sedation and analgesia
WX002 [2001310758]
3.3e-01
4.7e-01
—
—
3.2e+00
2.1e+00
9.0e-01
cases:3.47%
controls:2.53%
cases:1.21%
controls:0.77%
—
—
—
—
cases:0.98%
controls:0.04%
cases:4.08%
controls:0.53%
cases:5.00%
controls:2.10%
60
436
1670
16817
21
132
1709
17121
—
—
17
7
1712
17224
69
90
1623
16778
74
305
1407
14198
dexamethasone
D07AB19 [21602116]
2.8e-01
1.1e+00
—
—
2.8e+00
1.4e+00
8.4e-01
cases:1.39%
controls:1.05%
cases:0.81%
controls:0.28%
—
—
—
—
cases:0.87%
controls:0.05%
cases:1.89%
controls:0.46%
cases:3.44%
controls:1.52%
24
182
1706
17071
14
48
1716
17205
—
—
15
9
1714
17222
32
78
1660
16790
51
220
1430
14283
dexamethasone
D10AA03 [21602286]
2.8e-01
1.1e+00
—
—
2.8e+00
1.4e+00
8.4e-01
cases:1.39%
controls:1.05%
cases:0.81%
controls:0.28%
—
—
—
—
cases:0.87%
controls:0.05%
cases:1.89%
controls:0.46%
cases:3.44%
controls:1.52%
24
182
1706
17071
14
48
1716
17205
—
—
15
9
1714
17222
32
78
1660
16790
51
220
1430
14283
dexamethasone
S02BA06 [21605168]
2.8e-01
1.1e+00
—
—
2.8e+00
1.4e+00
8.4e-01
cases:1.39%
controls:1.05%
cases:0.81%
controls:0.28%
—
—
—
—
cases:0.87%
controls:0.05%
cases:1.89%
controls:0.46%
cases:3.44%
controls:1.52%
24
182
1706
17071
14
48
1716
17205
—
—
15
9
1714
17222
32
78
1660
16790
51
220
1430
14283
dexamethasone
C05AA09 [21601613]
2.8e-01
1.1e+00
—
—
2.8e+00
1.4e+00
8.4e-01
cases:1.39%
controls:1.05%
cases:0.81%
controls:0.28%
—
—
—
—
cases:0.87%
controls:0.05%
cases:1.89%
controls:0.46%
cases:3.44%
controls:1.52%
24
182
1706
17071
14
48
1716
17205
—
—
15
9
1714
17222
32
78
1660
16790
51
220
1430
14283
Eye, Other diagnostic procedure
F43 [2002000426]
1.7e+00
2.3e+00
—
—
—
2.1e+00
2.1e+00
cases:0.58%
controls:0.11%
cases:0.46%
controls:0.05%
—
—
—
—
—
—
cases:0.30%
controls:0.04%
cases:1.22%
controls:0.15%
10
19
1720
17234
8
8
1722
17245
—
—
—
5
6
1687
16862
18
22
1463
14481
Supplier / Service Provider
OMOP5117446 [33004]
-6.7e-01
-7.8e-01
—
—
2.3e+00
2.4e+00
2.8e+00
cases:14.97%
controls:25.64%
cases:3.76%
controls:7.82%
—
—
—
—
cases:0.40%
controls:0.04%
cases:5.32%
controls:0.53%
cases:15.73%
controls:1.10%
259
4423
1471
12830
65
1349
1665
15904
—
—
7
7
1722
17224
90
89
1602
16779
233
160
1248
14343
dexamethasone and antiinfectives
S01CA01 [21603652]
1.3e-01
1.1e+00
1.3e+00
—
2.6e+00
1.3e+00
8.6e-01
cases:1.45%
controls:1.28%
cases:1.04%
controls:0.34%
cases:0.29%
controls:0.08%
—
—
cases:0.87%
controls:0.06%
cases:1.89%
controls:0.52%
cases:3.78%
controls:1.63%
25
220
1705
17033
18
59
1712
17194
5
13
1725
17240
—
15
11
1714
17220
32
87
1660
16781
56
237
1425
14266
Dry eye syndrome
H04.10 [2000502254]
1.2e-01
1.2e+00
-1.0e+50
1.0e+50
2.5e+00
1.4e+00
7.9e-01
cases:1.04%
controls:0.92%
cases:1.10%
controls:0.32%
cases:0.00%
controls:0.03%
cases:0.29%
controls:0.00%
cases:0.40%
controls:0.03%
cases:1.60%
controls:0.39%
cases:3.24%
controls:1.50%
18
159
1712
17094
19
55
1711
17198
0
6
1730
17247
5
0
1725
17253
7
6
1722
17225
27
66
1665
16802
48
217
1433
14286
Visual field testing with Humphrey automated perimetry
CS434 [2001301476]
2.6e+00
—
—
1.0e+50
—
1.0e+50
3.3e+00
cases:0.52%
controls:0.04%
—
—
—
—
cases:0.98%
controls:0.00%
—
—
cases:1.65%
controls:0.00%
cases:2.43%
controls:0.09%
9
7
1721
17246
—
—
17
0
1713
17253
—
28
0
1664
16868
36
13
1445
14490
chloramphenicol
D10AF03 [21602307]
3.0e-01
1.3e+00
—
—
2.4e+00
1.2e+00
9.5e-01
cases:1.39%
controls:1.03%
cases:0.81%
controls:0.23%
—
—
—
—
cases:0.52%
controls:0.05%
cases:1.18%
controls:0.36%
cases:2.70%
controls:1.06%
24
178
1706
17075
14
39
1716
17214
—
—
9
8
1720
17223
20
60
1672
16808
40
154
1441
14349
chloramphenicol
S02AA01 [21605147]
3.0e-01
1.3e+00
—
—
2.4e+00
1.2e+00
9.5e-01
cases:1.39%
controls:1.03%
cases:0.81%
controls:0.23%
—
—
—
—
cases:0.52%
controls:0.05%
cases:1.18%
controls:0.36%
cases:2.70%
controls:1.06%
24
178
1706
17075
14
39
1716
17214
—
—
9
8
1720
17223
20
60
1672
16808
40
154
1441
14349
chloramphenicol
G01AA05 [21602367]
3.0e-01
1.3e+00
—
—
2.4e+00
1.2e+00
9.5e-01
cases:1.39%
controls:1.03%
cases:0.81%
controls:0.23%
—
—
—
—
cases:0.52%
controls:0.05%
cases:1.18%
controls:0.36%
cases:2.70%
controls:1.06%
24
178
1706
17075
14
39
1716
17214
—
—
9
8
1720
17223
20
60
1672
16808
40
154
1441
14349
chloramphenicol; ointment
D06AX02 [21602063]
3.0e-01
1.3e+00
—
—
2.4e+00
1.2e+00
9.5e-01
cases:1.39%
controls:1.03%
cases:0.81%
controls:0.23%
—
—
—
—
cases:0.52%
controls:0.05%
cases:1.18%
controls:0.36%
cases:2.70%
controls:1.06%
24
178
1706
17075
14
39
1716
17214
—
—
9
8
1720
17223
20
60
1672
16808
40
154
1441
14349
Pharmacy visit
OMOP4822462 [581458]
1.4e-01
4.2e-01
6.6e-01
2.7e+00
9.1e-01
6.9e-01
4.3e-01
cases:89.88%
controls:88.56%
cases:88.09%
controls:82.98%
cases:64.97%
controls:49.03%
cases:29.48%
controls:2.63%
cases:71.20%
controls:49.90%
cases:91.37%
controls:84.12%
cases:95.00%
controls:92.53%
1555
15280
175
1973
1524
14317
206
2936
1124
8460
606
8793
510
453
1220
16800
1231
8599
498
8632
1546
14189
146
2679
1407
13419
74
1084
Day surgery
ZXD20 [2001311388]
2.7e-01
8.4e-01
—
1.0e+50
3.2e+00
1.9e+00
6.9e-01
cases:1.33%
controls:1.02%
cases:0.58%
controls:0.25%
—
—
cases:0.29%
controls:0.00%
cases:0.87%
controls:0.03%
cases:1.36%
controls:0.21%
cases:2.36%
controls:1.20%
23
176
1707
17077
10
43
1720
17210
—
5
0
1725
17253
15
6
1714
17225
23
35
1669
16833
35
174
1446
14329
Primary open-angle glaucoma
H40.1 [45533312]
3.4e+00
—
—
—
—
—
2.4e+00
cases:2.20%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.06%
38
13
1692
17240
—
—
—
—
—
10
9
1471
14494
nepafenac
S01BC10 [21603648]
-5.6e-01
5.5e-01
—
—
2.8e+00
2.2e+00
7.7e-01
cases:0.64%
controls:1.11%
cases:0.75%
controls:0.43%
—
—
—
—
cases:0.64%
controls:0.04%
cases:3.66%
controls:0.43%
cases:4.32%
controls:2.04%
11
192
1719
17061
13
75
1717
17178
—
—
11
7
1718
17224
62
72
1630
16796
64
296
1417
14207
Emergency Medicine
93 [38004510]
8.2e-02
1.9e-01
9.4e-01
4.8e+00
6.6e-01
2.1e-01
1.9e-01
cases:11.33%
controls:10.53%
cases:7.17%
controls:5.99%
cases:2.60%
controls:1.03%
cases:3.93%
controls:0.03%
cases:1.56%
controls:0.81%
cases:8.22%
controls:6.73%
cases:21.67%
controls:18.64%
196
1817
1534
15436
124
1034
1606
16219
45
178
1685
17075
68
6
1662
17247
27
140
1702
17091
139
1136
1553
15732
321
2704
1160
11799
Medical doctor
Z2221 [2001311556]
2.8e-01
5.4e-01
1.3e+00
—
2.4e+00
1.1e+00
8.9e-01
cases:5.38%
controls:4.11%
cases:2.43%
controls:1.43%
cases:0.69%
controls:0.19%
—
—
cases:1.68%
controls:0.16%
cases:3.49%
controls:1.15%
cases:6.28%
controls:2.69%
93
709
1637
16544
42
247
1688
17006
12
33
1718
17220
—
29
27
1700
17204
59
194
1633
16674
93
390
1388
14113
One hour or less
ZXE00 [2001311394]
2.9e-01
5.8e-01
1.3e+00
—
2.3e+00
1.8e+00
8.1e-01
cases:7.57%
controls:5.78%
cases:2.77%
controls:1.58%
cases:0.58%
controls:0.16%
—
—
cases:1.56%
controls:0.16%
cases:6.74%
controls:1.13%
cases:9.32%
controls:4.36%
131
998
1599
16255
48
272
1682
16981
10
27
1720
17226
—
27
27
1702
17204
114
190
1578
16678
138
632
1343
13871
chloramphenicol
S03AA08 [21605197]
2.0e-01
7.2e-01
1.8e+00
—
1.7e+00
8.7e-01
4.6e-01
cases:6.99%
controls:5.81%
cases:3.58%
controls:1.78%
cases:1.50%
controls:0.25%
—
—
cases:1.21%
controls:0.23%
cases:5.02%
controls:2.16%
cases:10.87%
controls:7.16%
121
1002
1609
16251
62
307
1668
16946
26
43
1704
17210
—
21
39
1708
17192
85
365
1607
16503
161
1038
1320
13465
chloramphenicol
S01AA01 [21603554]
2.0e-01
7.2e-01
1.8e+00
—
1.7e+00
8.7e-01
4.6e-01
cases:6.99%
controls:5.81%
cases:3.58%
controls:1.78%
cases:1.50%
controls:0.25%
—
—
cases:1.21%
controls:0.23%
cases:5.02%
controls:2.16%
cases:10.87%
controls:7.16%
121
1002
1609
16251
62
307
1668
16946
26
43
1704
17210
—
21
39
1708
17192
85
365
1607
16503
161
1038
1320
13465
Scheduled procedure
ZXD10 [2001311387]
2.8e-01
3.7e-01
1.6e+00
—
1.9e+00
1.3e+00
7.6e-01
cases:7.98%
controls:6.17%
cases:2.54%
controls:1.77%
cases:0.69%
controls:0.14%
—
—
cases:1.10%
controls:0.16%
cases:5.20%
controls:1.51%
cases:8.85%
controls:4.34%
138
1065
1592
16188
44
305
1686
16948
12
25
1718
17228
—
19
28
1710
17203
88
255
1604
16613
131
629
1350
13874
Hypermetropia
H52.0 [45543078]
—
2.0e+00
—
1.0e+50
—
3.2e+00
2.2e+00
—
—
cases:0.29%
controls:0.04%
—
—
cases:0.64%
controls:0.00%
—
—
cases:0.83%
controls:0.04%
cases:1.22%
controls:0.13%
—
5
7
1725
17246
—
11
0
1719
17253
—
14
6
1678
16862
18
19
1463
14484
Case Management Agency
251B00000X [38004193]
1.6e-01
1.7e-01
4.1e-01
3.4e+00
7.6e-01
4.3e-01
2.1e-01
cases:59.08%
controls:55.08%
cases:52.20%
controls:47.95%
cases:25.84%
controls:18.83%
cases:24.86%
controls:1.13%
cases:33.55%
controls:19.04%
cases:60.82%
controls:50.16%
cases:71.91%
controls:67.57%
1022
9503
708
7750
903
8272
827
8981
447
3249
1283
14004
430
195
1300
17058
580
3281
1149
13950
1029
8461
663
8407
1065
9800
416
4703
Use of chemical agents
ZXC20 [2001311366]
6.5e-01
—
—
—
—
2.6e+00
2.5e+00
cases:0.29%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.03%
cases:1.28%
controls:0.10%
5
26
1725
17227
—
—
—
—
7
5
1685
16863
19
15
1462
14488
Intraocular pressure
41633001 [4216457]
—
—
—
—
—
2.8e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.04%
cases:1.15%
controls:0.11%
—
—
—
—
—
10
6
1682
16862
17
16
1464
14487
Type 1 diabetes mellitus, With ophthalmic complications
E10.3 [45552380]
1.4e+00
1.4e+00
1.6e+00
—
—
1.3e+00
1.0e+00
cases:1.50%
controls:0.37%
cases:0.92%
controls:0.23%
cases:0.35%
controls:0.07%
—
—
—
—
cases:0.89%
controls:0.24%
cases:1.28%
controls:0.47%
26
64
1704
17189
16
39
1714
17214
6
12
1724
17241
—
—
15
40
1677
16828
19
68
1462
14435
General Practice
1 [38004446]
4.4e-02
6.4e-02
7.6e-01
3.4e+00
8.8e-01
-2.4e-02
1.1e-01
cases:13.99%
controls:13.46%
cases:6.36%
controls:5.99%
cases:2.08%
controls:0.99%
cases:1.39%
controls:0.05%
cases:2.02%
controls:0.85%
cases:6.26%
controls:6.41%
cases:20.59%
controls:18.91%
242
2323
1488
14930
110
1033
1620
16220
36
170
1694
17083
24
8
1706
17245
35
147
1694
17084
106
1081
1586
15787
305
2742
1176
11761
Other healthcare associate professional
Z3229 [2001311561]
1.7e-01
8.8e-01
—
1.0e+50
2.3e+00
1.6e+00
1.0e+00
cases:1.39%
controls:1.18%
cases:0.69%
controls:0.29%
—
—
cases:0.46%
controls:0.00%
cases:0.35%
controls:0.03%
cases:1.83%
controls:0.37%
cases:2.63%
controls:0.96%
24
203
1706
17050
12
50
1718
17203
—
8
0
1722
17253
6
6
1723
17225
31
63
1661
16805
39
139
1442
14364
Puncture of vitreous body with injection of medication
CKD05 [2001301407]
7.9e-01
1.2e+00
7.8e-01
—
1.6e+00
1.4e+00
7.9e-01
cases:1.27%
controls:0.58%
cases:1.21%
controls:0.38%
cases:0.40%
controls:0.19%
—
—
cases:0.81%
controls:0.16%
cases:1.65%
controls:0.43%
cases:2.30%
controls:1.05%
22
100
1708
17153
21
66
1709
17187
7
32
1723
17221
—
14
28
1715
17203
28
72
1664
16796
34
153
1447
14350
Other minor procedure in eye surgery
TCW99 [2001301502]
1.0e+00
—
—
—
—
2.7e+00
2.2e+00
cases:0.35%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.05%
cases:1.08%
controls:0.12%
6
22
1724
17231
—
—
—
—
13
9
1679
16859
16
17
1465
14486
Neurology
13 [38004458]
2.3e-01
2.5e-01
8.1e-01
3.7e+00
6.7e-01
3.5e-01
2.9e-01
cases:12.43%
controls:10.09%
cases:5.49%
controls:4.35%
cases:1.50%
controls:0.67%
cases:1.45%
controls:0.03%
cases:1.50%
controls:0.77%
cases:6.26%
controls:4.49%
cases:14.25%
controls:11.08%
215
1741
1515
15512
95
750
1635
16503
26
116
1704
17137
25
6
1705
17247
26
133
1703
17098
106
758
1586
16110
211
1607
1270
12896
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.7e-01
3.9e-01
3.3e-01
3.3e+00
6.4e-01
2.9e-01
3.8e-01
cases:7.57%
controls:6.47%
cases:7.57%
controls:5.25%
cases:1.91%
controls:1.37%
cases:0.81%
controls:0.03%
cases:2.37%
controls:1.27%
cases:7.74%
controls:5.93%
cases:16.00%
controls:11.49%
131
1117
1599
16136
131
906
1599
16347
33
237
1697
17016
14
5
1716
17248
41
218
1688
17013
131
1001
1561
15867
237
1667
1244
12836
Corneal ulcer
H16.0 [45557339]
1.1e+00
1.9e+00
—
—
—
2.2e+00
1.5e+00
cases:0.81%
controls:0.27%
cases:0.35%
controls:0.05%
—
—
—
—
—
—
cases:0.71%
controls:0.08%
cases:1.62%
controls:0.38%
14
47
1716
17206
6
9
1724
17244
—
—
—
12
14
1680
16854
24
55
1457
14448
Presenil cataract
H26.02 [2000502303]
—
—
—
—
—
2.9e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.04%
cases:0.88%
controls:0.16%
—
—
—
—
—
13
7
1679
16861
13
23
1468
14480
Photocoagulation of retina
CKC12 [2001301394]
9.3e-01
2.0e+00
—
—
1.0e+50
1.7e+00
8.3e-01
cases:1.16%
controls:0.46%
cases:0.98%
controls:0.13%
—
—
—
—
cases:0.52%
controls:0.00%
cases:0.71%
controls:0.13%
cases:0.95%
controls:0.41%
20
79
1710
17174
17
23
1713
17230
—
—
9
0
1720
17231
12
22
1680
16846
14
60
1467
14443
Macular cyst
H35.36 [2000502316]
—
—
—
—
—
2.6e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.04%
cases:0.54%
controls:0.07%
—
—
—
—
—
9
7
1683
16861
8
10
1473
14493
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-1.4e-02
-1.5e-01
8.8e-01
3.6e+00
1.1e-01
1.8e-01
2.3e-01
cases:9.60%
controls:9.71%
cases:4.62%
controls:5.33%
cases:1.68%
controls:0.70%
cases:1.10%
controls:0.03%
cases:0.87%
controls:0.78%
cases:6.68%
controls:5.64%
cases:19.18%
controls:15.91%
166
1676
1564
15577
80
919
1650
16334
29
121
1701
17132
19
5
1711
17248
15
134
1714
17097
113
951
1579
15917
284
2307
1197
12196
Iridotomy
CHC05 [2001301259]
—
1.0e+50
1.0e+50
1.0e+50
—
—
4.4e+00
—
—
cases:3.99%
controls:0.00%
cases:1.62%
controls:0.00%
cases:26.94%
controls:0.00%
—
—
—
—
cases:2.84%
controls:0.03%
—
69
0
1661
17253
28
0
1702
17253
466
0
1264
17253
—
—
42
5
1439
14498
Visual field testing with Goldmann perimetry
CS424 [2001301475]
2.1e+00
—
—
—
—
—
2.3e+00
cases:0.35%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
cases:0.54%
controls:0.06%
6
7
1724
17246
—
—
—
—
—
8
8
1473
14495
Office Visit
OMOP4822458 [581477]
3.3e-01
4.2e-01
1.3e+00
—
1.9e+00
5.4e-01
3.1e-01
cases:10.46%
controls:7.74%
cases:3.70%
controls:2.46%
cases:1.04%
controls:0.30%
—
—
cases:2.02%
controls:0.30%
cases:4.26%
controls:2.52%
cases:9.72%
controls:7.31%
181
1335
1549
15918
64
424
1666
16829
18
51
1712
17202
—
35
51
1694
17180
72
425
1620
16443
144
1060
1337
13443
Senile incipient cataract
H25.0 [45576699]
2.2e-01
1.2e+00
—
1.0e+50
—
1.9e+00
1.3e+00
cases:0.87%
controls:0.70%
cases:0.69%
controls:0.20%
—
—
cases:1.16%
controls:0.00%
—
—
cases:1.65%
controls:0.26%
cases:3.85%
controls:1.09%
15
120
1715
17133
12
35
1718
17218
—
20
0
1710
17253
—
28
44
1664
16824
57
158
1424
14345
More than one and less than three hours
ZXE10 [2001311401]
3.5e-01
2.5e-01
1.6e+00
—
1.6e+00
8.7e-01
3.4e-01
cases:7.40%
controls:5.31%
cases:1.85%
controls:1.45%
cases:0.58%
controls:0.12%
—
—
cases:0.64%
controls:0.13%
cases:2.72%
controls:1.16%
cases:5.74%
controls:4.16%
128
916
1602
16337
32
250
1698
17003
10
21
1720
17232
—
11
23
1718
17208
46
195
1646
16673
85
603
1396
13900
Retinal detachment with retinal break
H33.0 [45547857]
1.2e+00
1.3e+00
—
1.0e+50
—
2.0e+00
1.1e+00
cases:0.75%
controls:0.23%
cases:0.35%
controls:0.09%
—
—
cases:0.35%
controls:0.00%
—
—
cases:0.89%
controls:0.12%
cases:1.08%
controls:0.35%
13
40
1717
17213
6
16
1724
17237
—
6
0
1724
17253
—
15
21
1677
16847
16
51
1465
14452
Essential (primary) hypertension
I10 [45591453]
2.4e-02
6.1e-02
1.8e-01
3.5e+00
6.7e-01
1.4e-01
1.5e-01
cases:20.00%
controls:19.61%
cases:10.58%
controls:10.02%
cases:1.97%
controls:1.65%
cases:2.43%
controls:0.08%
cases:3.24%
controls:1.68%
cases:11.94%
controls:10.53%
cases:29.44%
controls:26.37%
346
3384
1384
13869
183
1728
1547
15525
34
284
1696
16969
42
13
1688
17240
56
290
1673
16941
202
1777
1490
15091
436
3824
1045
10679
diclofenac
S01BC03 [21603641]
2.5e-01
1.0e+00
—
—
—
2.5e+00
1.6e+00
cases:0.46%
controls:0.36%
cases:0.35%
controls:0.13%
—
—
—
—
—
—
cases:1.24%
controls:0.11%
cases:2.50%
controls:0.50%
8
62
1722
17191
6
22
1724
17231
—
—
—
21
18
1671
16850
37
73
1444
14430
dexamethasone and antiinfectives
S03CA01 [21605206]
1.2e-01
7.9e-01
1.0e+00
—
2.4e+00
9.7e-01
6.8e-01
cases:2.14%
controls:1.91%
cases:1.27%
controls:0.58%
cases:0.29%
controls:0.10%
—
—
cases:0.87%
controls:0.08%
cases:1.89%
controls:0.72%
cases:4.32%
controls:2.23%
37
329
1693
16924
22
100
1708
17153
5
18
1725
17235
—
15
14
1714
17217
32
122
1660
16746
64
324
1417
14179
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
3.2e-01
3.6e-01
1.7e+00
—
1.6e+00
6.8e-01
6.9e-01
cases:2.08%
controls:1.52%
cases:1.27%
controls:0.89%
cases:0.52%
controls:0.10%
—
—
cases:0.58%
controls:0.12%
cases:1.54%
controls:0.78%
cases:4.19%
controls:2.14%
36
263
1694
16990
22
154
1708
17099
9
17
1721
17236
—
10
21
1719
17210
26
132
1666
16736
62
310
1419
14193
Electrophysiological examination of eye
XCD10 [2001300413]
1.6e+00
2.3e+00
—
—
—
1.7e+00
1.4e+00
cases:0.87%
controls:0.17%
cases:0.40%
controls:0.04%
—
—
—
—
—
—
cases:0.35%
controls:0.07%
cases:0.54%
controls:0.13%
15
30
1715
17223
7
7
1723
17246
—
—
—
6
11
1686
16857
8
19
1473
14484
Other visual field testing
CS494 [2001301478]
1.6e+00
—
—
1.0e+50
—
—
3.9e+00
cases:0.35%
controls:0.07%
—
—
—
—
cases:0.52%
controls:0.00%
—
—
—
—
cases:3.51%
controls:0.08%
6
12
1724
17241
—
—
9
0
1721
17253
—
—
52
11
1429
14492
Specialised imaging for glaucoma
CS5Z4 [2001301479]
—
1.0e+50
—
1.0e+50
—
—
3.9e+00
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.64%
controls:0.00%
—
—
—
—
cases:3.51%
controls:0.08%
—
7
0
1723
17253
—
11
0
1719
17253
—
—
52
11
1429
14492
Ocular pain
H57.1 [45596140]
1.0e+00
—
—
1.0e+50
—
2.2e+00
1.7e+00
cases:0.35%
controls:0.13%
—
—
—
—
cases:0.69%
controls:0.00%
—
—
cases:0.47%
controls:0.05%
cases:1.08%
controls:0.21%
6
22
1724
17231
—
—
12
0
1718
17253
—
8
9
1684
16859
16
30
1465
14473
betaxolol
S01ED02 [21603700]
3.6e+00
—
—
—
1.0e+50
—
—
cases:1.10%
controls:0.03%
—
—
—
—
—
—
cases:0.87%
controls:0.00%
—
—
—
—
19
5
1711
17248
—
—
—
15
0
1714
17231
—
—
tacrolimus; oral, parenteral
L04AD02 [21603925]
1.1e+00
1.4e+00
1.7e+00
—
—
1.7e+00
1.8e+00
cases:0.29%
controls:0.10%
cases:0.40%
controls:0.10%
cases:0.29%
controls:0.05%
—
—
—
—
cases:0.53%
controls:0.09%
cases:0.54%
controls:0.09%
5
17
1725
17236
7
18
1723
17235
5
9
1725
17244
—
—
9
16
1683
16852
8
13
1473
14490
ketorolac
S01BC05 [21603643]
-2.8e-01
—
—
—
—
2.6e+00
9.2e-01
cases:0.35%
controls:0.46%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.08%
cases:1.42%
controls:0.57%
6
79
1724
17174
—
—
—
—
18
14
1674
16854
21
83
1460
14420
dexamethasone; oral, parenteral
H02AB02 [21602730]
3.2e-02
4.8e-01
4.4e-01
—
1.9e+00
9.1e-01
6.6e-01
cases:2.25%
controls:2.19%
cases:1.27%
controls:0.79%
cases:0.29%
controls:0.19%
—
—
cases:0.93%
controls:0.15%
cases:2.25%
controls:0.92%
cases:4.79%
controls:2.53%
39
377
1691
16876
22
137
1708
17116
5
32
1725
17221
—
16
25
1713
17206
38
155
1654
16713
71
367
1410
14136
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
2.3e-02
-3.5e-02
4.7e-02
2.5e+00
6.4e-01
2.4e-01
2.7e-01
cases:14.80%
controls:14.51%
cases:7.75%
controls:8.00%
cases:1.21%
controls:1.16%
cases:0.35%
controls:0.03%
cases:2.14%
controls:1.14%
cases:10.28%
controls:8.24%
cases:26.27%
controls:21.40%
256
2504
1474
14749
134
1380
1596
15873
21
200
1709
17053
6
5
1724
17248
37
196
1692
17035
174
1390
1518
15478
389
3103
1092
11400
Malignant neoplasm of prostate
C61 [45547509]
2.8e-01
4.8e-01
9.8e-01
2.3e+00
5.9e-01
4.1e-01
4.8e-01
cases:2.43%
controls:1.85%
cases:2.14%
controls:1.34%
cases:0.92%
controls:0.35%
cases:0.46%
controls:0.05%
cases:0.64%
controls:0.35%
cases:2.30%
controls:1.54%
cases:3.85%
controls:2.42%
42
319
1688
16934
37
231
1693
17022
16
60
1714
17193
8
8
1722
17245
11
61
1718
17170
39
259
1653
16609
57
351
1424
14152
Infiltration anesthesia
WX110 [2001310767]
2.2e-01
2.4e-01
1.9e-02
2.3e+00
4.0e-01
6.1e-01
3.4e-01
cases:17.17%
controls:14.32%
cases:6.94%
controls:5.54%
cases:0.81%
controls:0.79%
cases:0.35%
controls:0.03%
cases:1.10%
controls:0.74%
cases:9.34%
controls:5.28%
cases:21.47%
controls:16.27%
297
2470
1433
14783
120
956
1610
16297
14
137
1716
17116
6
6
1724
17247
19
128
1710
17103
158
891
1534
15977
318
2360
1163
12143
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
-7.8e-03
1.3e-01
2.3e-01
2.7e+00
5.8e-01
1.3e-01
1.7e-01
cases:26.88%
controls:27.03%
cases:24.74%
controls:22.41%
cases:5.72%
controls:4.61%
cases:3.24%
controls:0.23%
cases:7.98%
controls:4.61%
cases:26.42%
controls:23.96%
cases:45.44%
controls:41.27%
465
4664
1265
12589
428
3866
1302
13387
99
795
1631
16458
56
40
1674
17213
138
795
1591
16436
447
4041
1245
12827
673
5986
808
8517
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
-1.0e-02
1.3e-01
2.2e-01
2.6e+00
5.9e-01
1.3e-01
1.7e-01
cases:26.99%
controls:27.20%
cases:25.09%
controls:22.73%
cases:5.78%
controls:4.71%
cases:3.24%
controls:0.24%
cases:8.16%
controls:4.71%
cases:26.65%
controls:24.26%
cases:45.51%
controls:41.39%
467
4692
1263
12561
434
3921
1296
13332
100
812
1630
16441
56
41
1674
17212
141
812
1588
16419
451
4092
1241
12776
674
6003
807
8500
Diabetic background retinopathy
H36.00 [2000502320]
1.7e+00
—
—
—
—
—
1.5e+00
cases:0.58%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.15%
10
18
1720
17235
—
—
—
—
—
10
22
1471
14481
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
-2.2e-02
9.9e-02
1.1e-01
2.6e+00
5.5e-01
1.2e-01
1.6e-01
cases:28.27%
controls:28.72%
cases:27.05%
controls:25.14%
cases:6.30%
controls:5.66%
cases:3.18%
controls:0.25%
cases:9.43%
controls:5.66%
cases:29.49%
controls:27.05%
cases:47.13%
controls:43.27%
489
4955
1241
12298
468
4338
1262
12915
109
976
1621
16277
55
43
1675
17210
163
975
1566
16256
499
4563
1193
12305
698
6275
783
8228
Internal Medicine
11 [38004456]
1.2e-01
1.2e-01
5.0e-01
2.9e+00
3.8e-01
1.6e-01
2.0e-01
cases:26.53%
controls:24.29%
cases:11.56%
controls:10.36%
cases:2.77%
controls:1.70%
cases:1.27%
controls:0.07%
cases:2.37%
controls:1.63%
cases:11.70%
controls:10.16%
cases:28.49%
controls:24.54%
459
4190
1271
13063
200
1787
1530
15466
48
294
1682
16959
22
12
1708
17241
41
281
1688
16950
198
1714
1494
15154
422
3559
1059
10944
Other specified counselling
Z71.8 [45581061]
5.4e-01
5.3e-01
1.1e+00
—
1.6e+00
9.7e-01
2.4e-01
cases:4.57%
controls:2.71%
cases:2.49%
controls:1.48%
cases:0.64%
controls:0.21%
—
—
cases:1.10%
controls:0.23%
cases:4.14%
controls:1.61%
cases:6.75%
controls:5.38%
79
468
1651
16785
43
256
1687
16997
11
37
1719
17216
—
19
39
1710
17192
70
271
1622
16597
100
780
1381
13723
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
4.6e-02
7.3e-02
1.1e-01
2.6e+00
4.3e-01
1.7e-01
1.7e-01
cases:20.23%
controls:19.50%
cases:18.44%
controls:17.37%
cases:4.39%
controls:3.95%
cases:2.14%
controls:0.16%
cases:5.84%
controls:3.87%
cases:21.63%
controls:18.85%
cases:35.58%
controls:31.81%
350
3364
1380
13889
319
2996
1411
14257
76
681
1654
16572
37
27
1693
17226
101
667
1628
16564
366
3180
1326
13688
527
4613
954
9890
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
5.3e-02
8.4e-02
2.0e-01
2.5e+00
5.6e-01
1.6e-01
1.5e-01
cases:23.41%
controls:22.47%
cases:16.71%
controls:15.57%
cases:4.10%
controls:3.38%
cases:2.49%
controls:0.21%
cases:5.61%
controls:3.30%
cases:18.56%
controls:16.23%
cases:37.34%
controls:33.85%
405
3876
1325
13377
289
2686
1441
14567
71
584
1659
16669
43
36
1687
17217
97
568
1632
16663
314
2737
1378
14131
553
4909
928
9594
CBC panel - Blood by Automated count
58410-2 [40761511]
1.4e-02
3.1e-02
1.7e-01
2.3e+00
4.6e-01
1.7e-01
2.0e-01
cases:25.32%
controls:25.04%
cases:18.79%
controls:18.32%
cases:3.99%
controls:3.39%
cases:1.73%
controls:0.17%
cases:5.38%
controls:3.46%
cases:21.10%
controls:18.37%
cases:39.84%
controls:35.25%
438
4321
1292
12932
325
3161
1405
14092
69
585
1661
16668
30
30
1700
17223
93
596
1636
16635
357
3098
1335
13770
590
5113
891
9390
Inpatient Visit
IP [9201]
2.1e-01
1.8e-01
6.0e-01
—
1.8e+00
7.1e-01
4.1e-01
cases:8.90%
controls:7.35%
cases:3.53%
controls:2.97%
cases:0.69%
controls:0.38%
—
—
cases:2.08%
controls:0.34%
cases:5.61%
controls:2.85%
cases:13.57%
controls:9.42%
154
1268
1576
15985
61
512
1669
16741
12
66
1718
17187
—
36
58
1693
17173
95
481
1597
16387
201
1366
1280
13137
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
-2.8e-02
-2.4e-01
-1.8e-01
2.9e+00
1.6e-01
-1.4e-01
2.0e-01
cases:5.90%
controls:6.05%
cases:2.54%
controls:3.22%
cases:0.46%
controls:0.55%
cases:0.52%
controls:0.03%
cases:0.75%
controls:0.64%
cases:3.19%
controls:3.66%
cases:9.93%
controls:8.29%
102
1044
1628
16209
44
556
1686
16697
8
95
1722
17158
9
5
1721
17248
13
110
1716
17121
54
618
1638
16250
147
1203
1334
13300
Remote contact by phone
ZYC01 [2001311579]
5.9e-01
—
—
—
—
1.7e+00
1.1e+00
cases:0.52%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.16%
cases:1.76%
controls:0.61%
9
50
1721
17203
—
—
—
—
15
27
1677
16841
26
88
1455
14415
Complicated cataract
H26.2 [45596054]
1.8e+00
—
—
—
—
—
2.8e+00
cases:0.35%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.06%
6
10
1724
17243
—
—
—
—
—
13
8
1468
14495
cyclopentolate
S01FA04 [21605063]
—
—
—
—
—
2.8e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.03%
cases:0.34%
controls:0.07%
—
—
—
—
—
8
5
1684
16863
5
10
1476
14493
Iridocyclitis, unspecified
H20.9 [45533269]
-1.0e+50
—
—
—
—
—
2.7e+00
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.04%
0
8
1730
17245
—
—
—
—
—
9
6
1472
14497
Platelets [#/volume] in Blood
26515-7 [3007461]
-1.5e-02
8.5e-02
1.0e-01
2.3e+00
4.1e-01
8.7e-02
1.4e-01
cases:29.36%
controls:29.68%
cases:28.21%
controls:26.51%
cases:6.65%
controls:6.05%
cases:2.95%
controls:0.31%
cases:9.02%
controls:6.17%
cases:29.85%
controls:28.06%
cases:48.01%
controls:44.49%
508
5121
1222
12132
488
4574
1242
12679
115
1044
1615
16209
51
54
1679
17199
156
1064
1573
16167
505
4734
1187
12134
711
6453
770
8050
MCH [Entitic mass]
28539-5 [3035941]
-1.8e-02
8.5e-02
9.9e-02
2.3e+00
4.1e-01
8.7e-02
1.4e-01
cases:29.31%
controls:29.69%
cases:28.21%
controls:26.52%
cases:6.65%
controls:6.06%
cases:2.95%
controls:0.31%
cases:9.02%
controls:6.17%
cases:29.85%
controls:28.06%
cases:47.94%
controls:44.51%
507
5122
1223
12131
488
4576
1242
12677
115
1045
1615
16208
51
54
1679
17199
156
1064
1573
16167
505
4734
1187
12134
710
6456
771
8047
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-1.1e-02
9.1e-02
1.0e-01
2.3e+00
4.1e-01
8.4e-02
1.4e-01
cases:29.54%
controls:29.76%
cases:28.38%
controls:26.57%
cases:6.71%
controls:6.08%
cases:2.95%
controls:0.31%
cases:9.02%
controls:6.19%
cases:29.85%
controls:28.12%
cases:48.08%
controls:44.50%
511
5134
1219
12119
491
4584
1239
12669
116
1049
1614
16204
51
54
1679
17199
156
1066
1573
16165
505
4743
1187
12125
712
6454
769
8049
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-1.7e-02
8.7e-02
9.8e-02
2.3e+00
4.1e-01
8.5e-02
1.4e-01
cases:29.36%
controls:29.73%
cases:28.27%
controls:26.53%
cases:6.65%
controls:6.06%
cases:2.95%
controls:0.31%
cases:9.02%
controls:6.19%
cases:29.85%
controls:28.11%
cases:48.01%
controls:44.52%
508
5129
1222
12124
489
4578
1241
12675
115
1046
1615
16207
51
54
1679
17199
156
1066
1573
16165
505
4741
1187
12127
711
6457
770
8046
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-2.0e-02
8.6e-02
1.1e-01
2.3e+00
4.1e-01
8.4e-02
1.4e-01
cases:29.31%
controls:29.73%
cases:28.27%
controls:26.55%
cases:6.71%
controls:6.07%
cases:2.95%
controls:0.31%
cases:9.02%
controls:6.19%
cases:29.85%
controls:28.11%
cases:47.94%
controls:44.54%
507
5129
1223
12124
489
4581
1241
12672
116
1047
1614
16206
51
54
1679
17199
156
1067
1573
16164
505
4742
1187
12126
710
6459
771
8044
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-1.8e-02
8.6e-02
1.1e-01
2.3e+00
4.1e-01
8.5e-02
1.4e-01
cases:29.36%
controls:29.73%
cases:28.27%
controls:26.56%
cases:6.71%
controls:6.07%
cases:2.95%
controls:0.31%
cases:9.02%
controls:6.20%
cases:29.85%
controls:28.11%
cases:48.01%
controls:44.54%
508
5130
1222
12123
489
4583
1241
12670
116
1048
1614
16205
51
54
1679
17199
156
1068
1573
16163
505
4741
1187
12127
711
6460
770
8043
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-1.6e-02
8.2e-02
1.1e-01
2.3e+00
4.1e-01
8.1e-02
1.4e-01
cases:29.42%
controls:29.75%
cases:28.21%
controls:26.58%
cases:6.76%
controls:6.07%
cases:2.95%
controls:0.31%
cases:9.02%
controls:6.20%
cases:29.85%
controls:28.18%
cases:48.01%
controls:44.58%
509
5132
1221
12121
488
4586
1242
12667
117
1048
1613
16205
51
54
1679
17199
156
1068
1573
16163
505
4753
1187
12115
711
6465
770
8038
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-7.0e-02
7.3e-02
9.5e-02
2.3e+00
3.9e-01
5.5e-02
1.4e-01
cases:17.34%
controls:18.37%
cases:17.11%
controls:16.10%
cases:4.05%
controls:3.69%
cases:2.14%
controls:0.23%
cases:5.32%
controls:3.67%
cases:17.73%
controls:16.94%
cases:32.14%
controls:29.13%
300
3169
1430
14084
296
2778
1434
14475
70
637
1660
16616
37
39
1693
17214
92
632
1637
16599
300
2857
1392
14011
476
4225
1005
10278
Sleep apnoea
G47.3 [45562094]
1.8e-01
6.7e-02
-1.1e-01
2.6e+00
2.9e-01
2.7e-02
1.4e-01
cases:4.45%
controls:3.73%
cases:2.54%
controls:2.38%
cases:0.40%
controls:0.45%
cases:0.40%
controls:0.03%
cases:0.58%
controls:0.44%
cases:2.66%
controls:2.59%
cases:5.67%
controls:4.97%
77
644
1653
16609
44
411
1686
16842
7
78
1723
17175
7
5
1723
17248
10
75
1719
17156
45
437
1647
16431
84
721
1397
13782
dexamethasone and antiinfectives
S02CA06 [21605178]
-4.9e-02
2.5e-01
—
—
2.6e+00
7.4e-01
3.5e-01
cases:0.87%
controls:0.91%
cases:0.46%
controls:0.36%
—
—
—
—
cases:0.46%
controls:0.03%
cases:0.77%
controls:0.37%
cases:1.69%
controls:1.20%
15
157
1715
17096
8
62
1722
17191
—
—
8
6
1721
17225
13
62
1679
16806
25
174
1456
14329
Ankylosing spondylitis
M45 [45591841]
1.2e+00
1.1e+00
—
—
—
8.7e-01
1.4e+00
cases:0.81%
controls:0.26%
cases:0.40%
controls:0.14%
—
—
—
—
—
—
cases:0.35%
controls:0.15%
cases:0.74%
controls:0.19%
14
44
1716
17209
7
24
1723
17229
—
—
—
6
25
1686
16843
11
28
1470
14475
Psychiatry
26 [38004469]
4.5e-01
7.3e-01
8.3e-01
—
4.3e-01
5.3e-01
4.8e-01
cases:4.97%
controls:3.23%
cases:3.18%
controls:1.55%
cases:1.27%
controls:0.56%
—
—
cases:1.04%
controls:0.68%
cases:2.60%
controls:1.55%
cases:4.79%
controls:3.03%
86
558
1644
16695
55
268
1675
16985
22
96
1708
17157
—
18
117
1711
17114
44
261
1648
16607
71
440
1410
14063
Body temperature
8310-5 [3020891]
6.8e-01
2.9e-01
2.5e+00
—
—
8.7e-01
5.4e-01
cases:0.87%
controls:0.44%
cases:0.35%
controls:0.26%
cases:0.35%
controls:0.03%
—
—
—
—
cases:0.65%
controls:0.27%
cases:1.62%
controls:0.95%
15
76
1715
17177
6
45
1724
17208
6
5
1724
17248
—
—
11
46
1681
16822
24
138
1457
14365
TREATMENT - Kidney transplant
TREATMENT-51 [2002330239]
2.5e+00
—
—
—
—
—
-1.0e+50
cases:0.35%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
6
5
1724
17248
—
—
—
—
—
0
7
1481
14496
Laser discission of secondary cataract
CJB10 [2001301313]
-2.0e-01
6.6e-01
—
1.0e+50
—
1.2e+00
1.3e+00
cases:0.81%
controls:0.99%
cases:0.64%
controls:0.33%
—
—
cases:0.75%
controls:0.00%
—
—
cases:1.00%
controls:0.31%
cases:5.40%
controls:1.52%
14
171
1716
17082
11
57
1719
17196
—
13
0
1717
17253
—
17
53
1675
16815
80
221
1401
14282
Microorganisms panel - Urine sediment
58435-9 [40761536]
6.2e-01
5.7e-01
9.2e-01
—
9.7e-01
8.6e-01
9.9e-01
cases:2.54%
controls:1.39%
cases:1.27%
controls:0.72%
cases:0.29%
controls:0.12%
—
—
cases:0.29%
controls:0.11%
cases:1.60%
controls:0.68%
cases:4.12%
controls:1.57%
44
239
1686
17014
22
125
1708
17128
5
20
1725
17233
—
5
19
1724
17212
27
115
1665
16753
61
227
1420
14276
aciclovir
S01AD03 [21603588]
9.9e-01
—
—
—
—
2.5e+00
1.3e+00
cases:0.64%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.04%
cases:0.68%
controls:0.18%
11
41
1719
17212
—
—
—
—
7
6
1685
16862
10
26
1471
14477
cromoglicic acid
S01GX01 [21605085]
4.1e-01
7.4e-01
1.7e+00
—
1.2e+00
6.6e-01
5.2e-01
cases:3.12%
controls:2.09%
cases:1.73%
controls:0.83%
cases:0.58%
controls:0.10%
—
—
cases:0.29%
controls:0.09%
cases:1.65%
controls:0.87%
cases:3.24%
controls:1.95%
54
360
1676
16893
30
144
1700
17109
10
18
1720
17235
—
5
15
1724
17216
28
146
1664
16722
48
283
1433
14220
Corneal transplant status
Z94.7 [45590780]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.04%
—
—
—
—
—
—
7
6
1474
14497
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.3e-01
-1.2e-01
—
—
1.7e+00
7.4e-01
3.8e-01
cases:2.54%
controls:2.23%
cases:0.64%
controls:0.71%
—
—
—
—
cases:0.46%
controls:0.09%
cases:1.89%
controls:0.91%
cases:3.78%
controls:2.61%
44
385
1686
16868
11
123
1719
17130
—
—
8
15
1721
17216
32
154
1660
16714
56
378
1425
14125
Combined vitrectomy and procedure on lens through pars plana
CKD94 [2001301426]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.05%
—
—
—
—
—
—
—
9
9
1683
16859
—
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
1.3e+00
—
—
—
—
2.3e+00
1.2e+00
cases:0.40%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.04%
cases:0.34%
controls:0.10%
7
19
1723
17234
—
—
—
—
6
6
1686
16862
5
15
1476
14488
Urology
34 [38004474]
2.6e-01
5.8e-01
8.8e-01
—
7.1e-01
4.3e-01
4.1e-01
cases:7.75%
controls:6.06%
cases:5.32%
controls:3.04%
cases:1.33%
controls:0.56%
—
—
cases:1.10%
controls:0.55%
cases:5.02%
controls:3.33%
cases:10.40%
controls:7.18%
134
1045
1596
16208
92
525
1638
16728
23
96
1707
17157
—
19
94
1710
17137
85
561
1607
16307
154
1041
1327
13462
Ultrasound oculometry
CA1ME [2001300876]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.07%
—
—
—
—
—
—
10
10
1471
14493
Release of ulnar nerve
ACC53 [2001300644]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.05%
—
—
—
—
—
—
7
7
1474
14496
Laboratory Visit
OMOP4822461 [32036]
-3.3e-02
6.3e-02
1.5e-01
1.9e+00
3.9e-01
6.2e-02
9.7e-02
cases:31.62%
controls:32.34%
cases:32.66%
controls:31.28%
cases:12.02%
controls:10.50%
cases:4.10%
controls:0.66%
cases:14.75%
controls:10.48%
cases:35.52%
controls:34.12%
cases:49.76%
controls:47.35%
547
5580
1183
11673
565
5397
1165
11856
208
1812
1522
15441
71
114
1659
17139
255
1806
1474
15425
601
5756
1091
11112
737
6867
744
7636
insulin aspart; parenteral
A10AB05 [21600719]
5.3e-01
5.9e-01
5.9e-01
—
7.6e-01
6.3e-01
5.0e-01
cases:3.41%
controls:2.03%
cases:3.41%
controls:1.92%
cases:0.75%
controls:0.42%
—
—
cases:1.04%
controls:0.49%
cases:3.72%
controls:2.03%
cases:4.79%
controls:2.96%
59
351
1671
16902
59
331
1671
16922
13
72
1717
17181
—
18
84
1711
17147
63
342
1629
16526
71
430
1410
14073
Preretinal fibrosis of the macula
H35.38 [2000502318]
3.2e-01
3.3e-01
—
1.0e+50
—
1.3e+00
9.3e-01
cases:0.46%
controls:0.34%
cases:0.29%
controls:0.21%
—
—
cases:0.35%
controls:0.00%
—
—
cases:0.77%
controls:0.21%
cases:1.42%
controls:0.57%
8
58
1722
17195
5
36
1725
17217
—
6
0
1724
17253
—
13
35
1679
16833
21
82
1460
14421
FEV1 --post bronchodilation
20155-8 [3023550]
3.9e-01
2.6e-01
—
—
—
1.1e+00
1.1e+00
cases:2.31%
controls:1.57%
cases:0.58%
controls:0.45%
—
—
—
—
—
—
cases:1.18%
controls:0.39%
cases:2.90%
controls:0.97%
40
271
1690
16982
10
77
1720
17176
—
—
—
20
66
1672
16802
43
140
1438
14363
FVC percent change Respiratory system
69982-7 [42868471]
3.9e-01
2.6e-01
—
—
—
1.1e+00
1.1e+00
cases:2.31%
controls:1.57%
cases:0.58%
controls:0.45%
—
—
—
—
—
—
cases:1.18%
controls:0.39%
cases:2.90%
controls:0.97%
40
271
1690
16982
10
77
1720
17176
—
—
—
20
66
1672
16802
43
140
1438
14363
FEV1/FVC --post bronchodilation
69970-2 [42868459]
3.9e-01
2.6e-01
—
—
—
1.1e+00
1.1e+00
cases:2.31%
controls:1.57%
cases:0.58%
controls:0.45%
—
—
—
—
—
—
cases:1.18%
controls:0.39%
cases:2.90%
controls:0.97%
40
271
1690
16982
10
77
1720
17176
—
—
—
20
66
1672
16802
43
140
1438
14363
FEV1 percent change
69983-5 [42868472]
3.9e-01
2.6e-01
—
—
—
1.1e+00
1.1e+00
cases:2.31%
controls:1.57%
cases:0.58%
controls:0.45%
—
—
—
—
—
—
cases:1.18%
controls:0.39%
cases:2.90%
controls:0.97%
40
271
1690
16982
10
77
1720
17176
—
—
—
20
66
1672
16802
43
140
1438
14363
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
3.9e-01
2.6e-01
—
—
—
1.1e+00
1.1e+00
cases:2.31%
controls:1.57%
cases:0.58%
controls:0.45%
—
—
—
—
—
—
cases:1.18%
controls:0.39%
cases:2.90%
controls:0.97%
40
271
1690
16982
10
77
1720
17176
—
—
—
20
66
1672
16802
43
140
1438
14363
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
4.6e-01
3.9e-01
—
—
-1.0e+50
1.1e+00
1.1e+00
cases:2.83%
controls:1.80%
cases:0.81%
controls:0.55%
—
—
—
—
cases:0.00%
controls:0.03%
cases:1.54%
controls:0.53%
cases:3.38%
controls:1.10%
49
311
1681
16942
14
95
1716
17158
—
—
0
5
1729
17226
26
89
1666
16779
50
160
1431
14343
FEV1/FVC
19926-5 [3011505]
4.6e-01
3.9e-01
—
—
-1.0e+50
1.1e+00
1.1e+00
cases:2.83%
controls:1.80%
cases:0.81%
controls:0.55%
—
—
—
—
cases:0.00%
controls:0.03%
cases:1.54%
controls:0.53%
cases:3.38%
controls:1.10%
49
311
1681
16942
14
95
1716
17158
—
—
0
5
1729
17226
26
89
1666
16779
50
160
1431
14343
FEV1
20150-9 [3024653]
4.6e-01
3.9e-01
—
—
-1.0e+50
1.1e+00
1.1e+00
cases:2.83%
controls:1.80%
cases:0.81%
controls:0.55%
—
—
—
—
cases:0.00%
controls:0.03%
cases:1.54%
controls:0.53%
cases:3.38%
controls:1.10%
49
311
1681
16942
14
95
1716
17158
—
—
0
5
1729
17226
26
89
1666
16779
50
160
1431
14343
Intravenous sedation or analgesia without general anesthesia
WX006 [2001310762]
—
—
—
—
—
2.2e+00
5.5e-01
—
—
—
—
—
—
—
—
—
—
cases:1.54%
controls:0.17%
cases:1.42%
controls:0.82%
—
—
—
—
—
26
29
1666
16839
21
119
1460
14384
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-1.8e-01
-6.6e-02
3.1e-02
2.2e+00
2.8e-01
-1.2e-01
-1.1e-01
cases:18.84%
controls:21.68%
cases:17.05%
controls:18.01%
cases:4.10%
controls:3.98%
cases:2.08%
controls:0.24%
cases:5.38%
controls:4.11%
cases:17.26%
controls:18.98%
cases:30.25%
controls:32.64%
326
3740
1404
13513
295
3107
1435
14146
71
687
1659
16566
36
41
1694
17212
93
708
1636
16523
292
3202
1400
13666
448
4734
1033
9769
insulin aspart; parenteral
A10AD05 [21600733]
5.1e-01
5.7e-01
5.4e-01
—
7.3e-01
6.0e-01
4.9e-01
cases:3.41%
controls:2.07%
cases:3.41%
controls:1.96%
cases:0.75%
controls:0.44%
—
—
cases:1.04%
controls:0.50%
cases:3.72%
controls:2.09%
cases:4.86%
controls:3.03%
59
357
1671
16896
59
338
1671
16915
13
76
1717
17177
—
18
87
1711
17144
63
352
1629
16516
72
439
1409
14064
Macular holes
H35.37 [2000502317]
—
2.2e+00
—
—
—
1.6e+00
4.9e-01
—
—
cases:0.40%
controls:0.05%
—
—
—
—
—
—
cases:0.30%
controls:0.06%
cases:0.34%
controls:0.21%
—
7
8
1723
17245
—
—
—
5
10
1687
16858
5
30
1476
14473
Prolonged inflammation in the edge of the eyelid
H01.80 [2000502240]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.06%
—
—
—
—
—
—
7
8
1474
14495
dexpanthenol
D03AX03 [21601991]
2.1e+00
—
—
—
—
—
—
cases:0.35%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
1724
17246
—
—
—
—
—
—
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
—
2.1e+00
—
—
—
—
—
—
—
cases:0.35%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
6
7
1724
17246
—
—
—
—
—
Type 1 diabetes mellitus, With renal complications
E10.2 [45586137]
1.6e+00
—
—
—
—
2.1e+00
1.4e+00
cases:0.40%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.04%
cases:0.41%
controls:0.10%
7
14
1723
17239
—
—
—
—
6
7
1686
16861
6
15
1475
14488
scopolamine
S01FA02 [21605061]
1.4e+00
—
—
—
—
—
2.1e+00
cases:0.46%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.10%
8
20
1722
17233
—
—
—
—
—
12
14
1469
14489
Retinoschisis and retinal cysts
H33.1 [45571949]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.05%
—
—
—
—
—
—
6
7
1475
14496
Eye/adnexa disease other
F99 [2002000473]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.05%
—
—
—
—
—
—
6
7
1475
14496
Keratitis, unspecified
H16.9 [45605629]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.54%
controls:0.07%
—
—
—
—
—
—
8
10
1473
14493
Urgent procedure
ZXD05 [2001311386]
2.7e-01
2.2e-01
1.1e+00
—
2.0e+00
2.5e-01
1.9e-01
cases:4.57%
controls:3.54%
cases:1.33%
controls:1.07%
cases:0.35%
controls:0.12%
—
—
cases:0.87%
controls:0.12%
cases:1.24%
controls:0.97%
cases:4.32%
controls:3.61%
79
610
1651
16643
23
184
1707
17069
6
20
1724
17233
—
15
20
1714
17211
21
164
1671
16704
64
523
1417
13980
Transplant complication
127 [2001600125]
2.0e+00
—
—
—
—
—
—
cases:0.35%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
1724
17245
—
—
—
—
—
—
Herpesviral keratoconjunctivitis
H19.1*B00.5 [2000502280]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.06%
—
—
—
—
—
—
6
8
1475
14495
dexamethasone
S01CB01 [21603664]
-1.0e+50
-1.0e+50
—
—
—
2.0e+00
5.4e-01
cases:0.00%
controls:0.03%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:0.77%
controls:0.11%
cases:0.81%
controls:0.48%
0
5
1730
17248
0
9
1730
17244
—
—
—
13
18
1679
16850
12
69
1469
14434
artificial tears and other indifferent preparations
S01XA20 [21605143]
-1.0e+50
-1.0e+50
—
—
—
2.0e+00
6.2e-01
cases:0.00%
controls:0.03%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:0.77%
controls:0.11%
cases:0.88%
controls:0.48%
0
5
1730
17248
0
9
1730
17244
—
—
—
13
18
1679
16850
13
69
1468
14434
phenylephrine, combinations
S01GA55 [21605082]
-1.0e+50
-1.0e+50
—
—
—
2.0e+00
5.4e-01
cases:0.00%
controls:0.03%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:0.77%
controls:0.11%
cases:0.81%
controls:0.48%
0
5
1730
17248
0
9
1730
17244
—
—
—
13
18
1679
16850
12
69
1469
14434
INR in Blood by Coagulation assay
34714-6 [3032080]
-3.1e-02
2.0e-02
3.1e-01
2.0e+00
2.2e-01
1.7e-01
1.8e-01
cases:8.61%
controls:8.86%
cases:5.84%
controls:5.73%
cases:2.77%
controls:2.05%
cases:1.16%
controls:0.16%
cases:2.43%
controls:1.96%
cases:6.86%
controls:5.84%
cases:16.07%
controls:13.82%
149
1529
1581
15724
101
988
1629
16265
48
353
1682
16900
20
28
1710
17225
42
337
1687
16894
116
985
1576
15883
238
2005
1243
12498
General and Unspecified, Observ/health educat/advice/diet
A45 [2002000179]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.07%
—
—
—
—
—
—
7
10
1474
14493
Cataract, Senile cataract
3661A [2000403305]
—
—
—
1.0e+50
—
—
1.9e+00
—
—
—
—
—
—
cases:0.29%
controls:0.00%
—
—
—
—
cases:0.74%
controls:0.11%
—
—
—
5
0
1725
17253
—
—
11
16
1470
14487
bromfenac
S01BC11 [21603649]
—
—
—
—
—
1.9e+00
6.0e-01
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.11%
cases:0.88%
controls:0.48%
—
—
—
—
—
12
18
1680
16850
13
70
1468
14433
Assessment of vision
XCW10 [2001301503]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.16%
—
—
—
—
—
—
15
23
1466
14480
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
3.9e-01
1.1e+00
—
—
—
-1.1e-01
7.2e-01
cases:1.50%
controls:1.02%
cases:0.81%
controls:0.26%
—
—
—
—
—
—
cases:0.35%
controls:0.40%
cases:2.16%
controls:1.06%
26
176
1704
17077
14
45
1716
17208
—
—
—
6
67
1686
16801
32
154
1449
14349
Endophotocoagulation of retina
CKD40 [2001301413]
1.8e+00
—
—
—
—
—
1.3e+00
cases:0.46%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.11%
8
13
1722
17240
—
—
—
—
—
6
16
1475
14487
Elevated blood-pressure reading, without diagnosis of hypertension
R03.0 [45553712]
-1.7e-01
—
—
—
—
1.8e+00
5.7e-01
cases:0.29%
controls:0.34%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.08%
cases:0.61%
controls:0.34%
5
59
1725
17194
—
—
—
—
8
13
1684
16855
9
50
1472
14453
Extracapsular cataract surgery and implantation of an artificial lens
3626 [2000100402]
—
—
—
1.0e+50
—
—
1.8e+00
—
—
—
—
—
—
cases:0.29%
controls:0.00%
—
—
—
—
cases:0.81%
controls:0.14%
—
—
—
5
0
1725
17253
—
—
12
20
1469
14483
HLA-B27 [Presence]
4821-5 [3008898]
2.8e-01
—
—
—
—
1.8e+00
7.3e-01
cases:0.40%
controls:0.31%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.07%
cases:0.74%
controls:0.36%
7
53
1723
17200
—
—
—
—
7
12
1685
16856
11
52
1470
14451
Panretinal photocoagulation
CKC15 [2001301395]
1.7e+00
—
—
—
—
—
—
cases:0.69%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
12
21
1718
17232
—
—
—
—
—
—
Wedge excision of mammary gland
HAB40 [2001303928]
-5.5e-01
—
—
—
—
—
1.7e+00
cases:0.35%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.20%
6
103
1724
17150
—
—
—
—
—
16
29
1465
14474
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
1.7e+00
—
—
—
—
-1.0e+50
8.2e-01
cases:0.46%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.41%
controls:0.18%
8
15
1722
17238
—
—
—
—
0
5
1692
16863
6
26
1475
14477
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
5.1e-01
1.1e+00
—
—
—
1.7e+00
3.1e-01
cases:0.87%
controls:0.52%
cases:0.46%
controls:0.15%
—
—
—
—
—
—
cases:0.47%
controls:0.09%
cases:0.68%
controls:0.50%
15
90
1715
17163
8
26
1722
17227
—
—
—
8
15
1684
16853
10
72
1471
14431
Cell count and differential, peritoneal fluid
67017004 [4281824]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.54%
controls:0.10%
—
—
—
—
—
—
8
15
1473
14488
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83.1 [45547251]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.54%
controls:0.10%
—
—
—
—
—
—
8
15
1473
14488
combinations of corticosteroids
D07AB30 [21602118]
2.5e-01
4.0e-01
4.4e-01
—
9.0e-01
3.5e-01
3.5e-01
cases:13.18%
controls:10.61%
cases:5.66%
controls:3.88%
cases:0.75%
controls:0.49%
—
—
cases:1.27%
controls:0.52%
cases:5.44%
controls:3.91%
cases:14.92%
controls:10.97%
228
1830
1502
15423
98
670
1632
16583
13
84
1717
17169
—
22
90
1707
17141
92
659
1600
16209
221
1591
1260
12912
combinations of corticosteroids
D07XB30 [21602188]
2.5e-01
4.0e-01
4.4e-01
—
9.0e-01
3.5e-01
3.5e-01
cases:13.18%
controls:10.61%
cases:5.66%
controls:3.88%
cases:0.75%
controls:0.49%
—
—
cases:1.27%
controls:0.52%
cases:5.44%
controls:3.91%
cases:14.92%
controls:10.97%
228
1830
1502
15423
98
670
1632
16583
13
84
1717
17169
—
22
90
1707
17141
92
659
1600
16209
221
1591
1260
12912
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.14%
—
—
—
—
—
—
10
20
1471
14483
Eye, Other laboratory test NEC
F38 [2002000421]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.12%
—
—
—
—
—
—
9
18
1472
14485
adalimumab; parenteral
L04AB04 [21603911]
1.2e+00
1.6e+00
—
—
—
1.5e+00
1.1e+00
cases:0.46%
controls:0.14%
cases:0.52%
controls:0.11%
—
—
—
—
—
—
cases:0.47%
controls:0.11%
cases:0.41%
controls:0.13%
8
24
1722
17229
9
19
1721
17234
—
—
—
8
18
1684
16850
6
19
1475
14484
Degeneration of macula and posterior pole
H35.39 [2000502319]
9.6e-01
1.3e+00
—
—
—
1.6e+00
1.1e+00
cases:0.75%
controls:0.29%
cases:0.46%
controls:0.13%
—
—
—
—
—
—
cases:0.53%
controls:0.11%
cases:0.81%
controls:0.26%
13
50
1717
17203
8
22
1722
17231
—
—
—
9
19
1683
16849
12
38
1469
14465
Lesion of ulnar nerve
G56.2 [45595951]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.17%
—
—
—
—
—
—
12
25
1469
14478
Acute pain
R52.0 [45573031]
—
—
—
—
—
-1.0e+50
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:0.81%
controls:0.17%
—
—
—
—
—
0
15
1692
16853
12
25
1469
14478
Extensive CT examination of thorax for dose design of radiotherapy
YG1BD [2001303664]
—
—
—
—
—
1.6e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.06%
cases:0.61%
controls:0.13%
—
—
—
—
—
5
10
1687
16858
9
19
1472
14484
Hypothyroidism, unspecified
E03.9 [45537945]
9.5e-02
2.7e-01
—
1.0e+50
1.5e+00
1.5e-01
2.0e-01
cases:2.08%
controls:1.90%
cases:1.10%
controls:0.84%
—
—
cases:0.40%
controls:0.00%
cases:0.58%
controls:0.13%
cases:1.12%
controls:0.97%
cases:3.31%
controls:2.72%
36
327
1694
16926
19
145
1711
17108
—
7
0
1723
17253
10
22
1719
17209
19
163
1673
16705
49
394
1432
14109
salmeterol; inhalant
R03AC12 [21603266]
5.1e-01
7.4e-01
1.3e+00
—
1.5e+00
8.1e-01
8.0e-01
cases:1.27%
controls:0.77%
cases:0.87%
controls:0.42%
cases:0.35%
controls:0.09%
—
—
cases:0.52%
controls:0.12%
cases:0.89%
controls:0.40%
cases:1.08%
controls:0.49%
22
132
1708
17121
15
72
1715
17181
6
16
1724
17237
—
9
20
1720
17211
15
67
1677
16801
16
71
1465
14432
alprazolam; oral
N05BA12 [21604577]
2.4e-01
7.3e-01
4.9e-01
—
4.3e-01
7.4e-01
6.0e-01
cases:1.91%
controls:1.51%
cases:1.68%
controls:0.81%
cases:0.46%
controls:0.28%
—
—
cases:0.35%
controls:0.23%
cases:1.54%
controls:0.74%
cases:2.23%
controls:1.23%
33
260
1697
16993
29
140
1701
17113
8
49
1722
17204
—
6
39
1723
17192
26
125
1666
16743
33
179
1448
14324
Other gynecological ultrasound examination
LX1XE [2001306816]
—
—
—
—
—
-1.0e+50
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:0.68%
controls:0.16%
—
—
—
—
—
0
15
1692
16853
10
23
1471
14480
Local photocoagulation of retina
CKC10 [2001301393]
1.4e+00
—
—
—
—
—
1.3e+00
cases:0.64%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.13%
11
26
1719
17227
—
—
—
—
—
7
19
1474
14484
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 [3030692]
—
-1.0e+50
—
—
—
—
1.4e+00
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.19%
—
0
14
1730
17239
—
—
—
—
12
28
1469
14475
Kidney transplant status
Z94.0 [45566477]
1.2e+00
1.2e+00
—
—
—
1.4e+00
1.4e+00
cases:0.40%
controls:0.13%
cases:0.46%
controls:0.13%
—
—
—
—
—
—
cases:0.59%
controls:0.14%
cases:0.61%
controls:0.14%
7
22
1723
17231
8
23
1722
17230
—
—
—
10
24
1682
16844
9
21
1472
14482
Eye symptom/complaint other
F29 [2002000412]
6.2e-02
7.7e-01
—
—
—
1.4e+00
4.2e-01
cases:0.92%
controls:0.87%
cases:0.64%
controls:0.30%
—
—
—
—
—
—
cases:0.83%
controls:0.20%
cases:2.09%
controls:1.38%
16
150
1714
17103
11
51
1719
17202
—
—
—
14
34
1678
16834
31
200
1450
14303
Blepharochalasis
H02.3 [45586340]
1.4e-02
4.1e-01
—
—
—
1.4e+00
2.4e-03
cases:0.69%
controls:0.68%
cases:0.29%
controls:0.19%
—
—
—
—
—
—
cases:0.89%
controls:0.22%
cases:0.88%
controls:0.88%
12
118
1718
17135
5
33
1725
17220
—
—
—
15
37
1677
16831
13
127
1468
14376
Radiotherapy after partial ablation of mammary gland
HA003 [2001303965]
-3.5e-01
-1.0e+50
—
—
—
—
1.4e+00
cases:0.35%
controls:0.49%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.74%
controls:0.19%
6
85
1724
17168
0
26
1730
17227
—
—
—
—
11
27
1470
14476
Shoulder extensive X-ray examination without contrast
NB1BA [2001307228]
4.6e-01
—
—
—
—
—
1.4e+00
cases:0.35%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.26%
6
38
1724
17215
—
—
—
—
—
15
37
1466
14466
retinol
S01XA02 [21605128]
7.7e-01
1.7e+00
—
—
—
1.5e+00
1.4e+00
cases:0.46%
controls:0.21%
cases:0.35%
controls:0.06%
—
—
—
—
—
—
cases:0.35%
controls:0.08%
cases:0.95%
controls:0.24%
8
37
1722
17216
6
11
1724
17242
—
—
—
6
14
1686
16854
14
35
1467
14468
Teaching
WZC30 [2001310891]
1.8e-01
3.5e-01
—
—
1.3e+00
7.7e-01
6.0e-01
cases:1.85%
controls:1.55%
cases:1.21%
controls:0.86%
—
—
—
—
cases:0.29%
controls:0.08%
cases:1.60%
controls:0.75%
cases:3.92%
controls:2.19%
32
268
1698
16985
21
148
1709
17105
—
—
5
13
1724
17218
27
126
1665
16742
58
318
1423
14185
Other specified special examinations
Z01.8 [45581003]
-1.2e-01
-1.1e-01
—
—
—
7.9e-01
5.7e-01
cases:2.25%
controls:2.53%
cases:0.75%
controls:0.84%
—
—
—
—
—
—
cases:1.71%
controls:0.78%
cases:4.93%
controls:2.85%
39
436
1691
16817
13
145
1717
17108
—
—
—
29
132
1663
16736
73
413
1408
14090
Granulocytes [#/volume] in Blood
30394-1 [3035715]
5.5e-01
—
—
—
-1.0e+50
1.3e+00
1.4e+00
cases:0.52%
controls:0.30%
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.30%
controls:0.08%
cases:0.88%
controls:0.23%
9
52
1721
17201
—
—
—
0
5
1729
17226
5
13
1687
16855
13
33
1468
14470
Endocrinology
46 [38004485]
2.4e-01
3.0e-01
1.0e+00
—
7.2e-01
6.4e-01
7.1e-01
cases:2.60%
controls:2.05%
cases:1.62%
controls:1.20%
cases:0.58%
controls:0.21%
—
—
cases:0.46%
controls:0.23%
cases:2.13%
controls:1.13%
cases:4.79%
controls:2.42%
45
354
1685
16899
28
207
1702
17046
10
36
1720
17217
—
8
39
1721
17192
36
191
1656
16677
71
351
1410
14152
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
2.9e-02
6.2e-02
1.8e-02
—
1.3e+00
1.8e-01
2.8e-01
cases:3.41%
controls:3.32%
cases:1.79%
controls:1.69%
cases:0.29%
controls:0.28%
—
—
cases:1.04%
controls:0.27%
cases:1.95%
controls:1.63%
cases:4.19%
controls:3.19%
59
572
1671
16681
31
291
1699
16962
5
49
1725
17204
—
18
47
1711
17184
33
275
1659
16593
62
463
1419
14040
Base excess in Blood by calculation
11555-0 [3012501]
7.5e-01
—
—
—
—
1.1e+00
1.3e+00
cases:0.64%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.11%
cases:0.95%
controls:0.26%
11
52
1719
17201
—
—
—
—
6
19
1686
16849
14
38
1467
14465
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
7.5e-01
—
—
—
—
1.1e+00
1.3e+00
cases:0.64%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.11%
cases:0.95%
controls:0.26%
11
52
1719
17201
—
—
—
—
6
19
1686
16849
14
38
1467
14465
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
7.5e-01
—
—
—
—
1.1e+00
1.3e+00
cases:0.64%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.11%
cases:0.95%
controls:0.26%
11
52
1719
17201
—
—
—
—
6
19
1686
16849
14
38
1467
14465
Shoulder symptom/complaint
L08 [2002000632]
3.1e-01
7.8e-01
—
—
5.8e-01
2.1e-01
4.9e-01
cases:2.89%
controls:2.14%
cases:1.73%
controls:0.81%
—
—
—
—
cases:0.29%
controls:0.16%
cases:1.24%
controls:1.01%
cases:5.06%
controls:3.15%
50
369
1680
16884
30
139
1700
17114
—
—
5
28
1724
17203
21
170
1671
16698
75
457
1406
14046
Breast Pathology biopsy report
66110-8 [40768793]
4.0e-01
-1.0e+50
—
—
—
—
1.3e+00
cases:0.52%
controls:0.35%
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.25%
9
60
1721
17193
0
20
1730
17233
—
—
—
—
13
36
1468
14467
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.5e-02
4.7e-03
8.9e-01
—
7.1e-01
2.2e-01
3.6e-01
cases:5.84%
controls:5.70%
cases:3.18%
controls:3.16%
cases:1.10%
controls:0.45%
—
—
cases:0.93%
controls:0.46%
cases:4.14%
controls:3.33%
cases:12.69%
controls:9.25%
101
984
1629
16269
55
546
1675
16707
19
78
1711
17175
—
16
79
1713
17152
70
562
1622
16306
188
1341
1293
13162
Radiotherapy with large shaped fields - isocentric therapy
ZX012 [2001311468]
-4.2e-02
—
—
—
—
—
1.2e+00
cases:0.58%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.26%
10
104
1720
17149
—
—
—
—
—
13
37
1468
14466
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
7.2e-01
8.7e-01
—
—
—
1.2e+00
5.6e-01
cases:1.27%
controls:0.63%
cases:0.58%
controls:0.24%
—
—
—
—
—
—
cases:0.83%
controls:0.24%
cases:1.28%
controls:0.74%
22
108
1708
17145
10
42
1720
17211
—
—
—
14
41
1678
16827
19
107
1462
14396
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
5.8e-01
-5.6e-01
-1.0e+50
—
—
6.8e-01
6.5e-01
cases:2.43%
controls:1.38%
cases:0.29%
controls:0.50%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.83%
controls:0.42%
cases:2.90%
controls:1.53%
42
238
1688
17015
5
87
1725
17166
0
10
1730
17243
—
—
14
71
1678
16797
43
222
1438
14281
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
2.2e-01
1.9e-01
1.5e-01
—
1.2e+00
7.5e-02
1.2e-01
cases:4.34%
controls:3.52%
cases:2.37%
controls:1.96%
cases:0.29%
controls:0.25%
—
—
cases:0.81%
controls:0.24%
cases:2.42%
controls:2.25%
cases:7.90%
controls:7.04%
75
608
1655
16645
41
339
1689
16914
5
43
1725
17210
—
14
42
1715
17189
41
380
1651
16488
117
1021
1364
13482
Rhinopharyngoscopy
UDH02 [2001301680]
4.4e-01
9.2e-01
—
—
—
—
1.2e+00
cases:0.75%
controls:0.49%
cases:0.29%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.39%
13
84
1717
17169
5
20
1725
17233
—
—
—
—
19
57
1462
14446
clonazepam; oral, parenteral
N03AE01 [21604415]
2.5e-01
6.1e-01
—
—
—
8.4e-01
1.2e+00
cases:0.87%
controls:0.68%
cases:0.75%
controls:0.41%
—
—
—
—
—
—
cases:0.89%
controls:0.39%
cases:1.96%
controls:0.61%
15
117
1715
17136
13
71
1717
17182
—
—
—
15
65
1677
16803
29
88
1452
14415
pH of Blood
11558-4 [3010421]
7.8e-01
—
—
—
—
1.2e+00
1.2e+00
cases:0.69%
controls:0.32%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.18%
cases:1.35%
controls:0.42%
12
55
1718
17198
—
—
—
—
10
31
1682
16837
20
61
1461
14442
General Practice Dentistry
1223G0001X [38003675]
9.0e-01
9.9e-01
—
—
—
1.3e+00
1.2e+00
cases:0.81%
controls:0.33%
cases:0.40%
controls:0.15%
—
—
—
—
—
—
cases:0.53%
controls:0.15%
cases:1.08%
controls:0.34%
14
57
1716
17196
7
26
1723
17227
—
—
—
9
25
1683
16843
16
49
1465
14454
Thorax extensive CT-examination
GD1BD [2001303621]
-5.0e-01
—
—
—
—
—
1.2e+00
cases:0.29%
controls:0.48%
—
—
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.32%
5
82
1725
17171
—
—
—
—
—
15
46
1466
14457
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
6.1e-01
8.9e-01
—
—
—
1.1e+00
1.2e+00
cases:0.40%
controls:0.22%
cases:0.52%
controls:0.21%
—
—
—
—
—
—
cases:0.71%
controls:0.23%
cases:0.88%
controls:0.28%
7
38
1723
17215
9
37
1721
17216
—
—
—
12
39
1680
16829
13
40
1468
14463
After-cataract
H26.4 [45600893]
-2.2e-01
-5.9e-02
—
—
—
7.3e-01
1.2e+00
cases:0.98%
controls:1.22%
cases:0.40%
controls:0.43%
—
—
—
—
—
—
cases:0.95%
controls:0.46%
cases:6.14%
controls:2.01%
17
211
1713
17042
7
74
1723
17179
—
—
—
16
77
1676
16791
91
291
1390
14212
oxcarbazepine; oral
N03AF02 [21604418]
7.6e-01
1.2e+00
1.5e+00
—
—
7.6e-01
6.3e-01
cases:0.75%
controls:0.35%
cases:0.81%
controls:0.26%
cases:0.35%
controls:0.08%
—
—
—
—
cases:0.53%
controls:0.25%
cases:0.61%
controls:0.32%
13
61
1717
17192
14
44
1716
17209
6
14
1724
17239
—
—
9
42
1683
16826
9
47
1472
14456
hydrocortisone
S01CB03 [21603666]
—
1.0e+00
—
—
—
—
1.2e+00
—
—
cases:0.35%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.39%
—
6
21
1724
17232
—
—
—
—
18
56
1463
14447
hydrocortisone
S01BA02 [21603619]
—
1.0e+00
—
—
—
—
1.2e+00
—
—
cases:0.35%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.39%
—
6
21
1724
17232
—
—
—
—
18
56
1463
14447
Rheumatology
66 [38004491]
4.6e-01
4.6e-01
1.0e-01
—
8.1e-01
6.8e-01
4.0e-01
cases:4.51%
controls:2.90%
cases:2.77%
controls:1.76%
cases:0.46%
controls:0.42%
—
—
cases:0.75%
controls:0.34%
cases:3.07%
controls:1.58%
cases:4.52%
controls:3.08%
78
500
1652
16753
48
304
1682
16949
8
72
1722
17181
—
13
58
1716
17173
52
266
1640
16602
67
447
1414
14056
Sentinel node biopsy
PJA12 [2001309627]
-1.3e-01
1.3e-01
—
—
—
8.8e-01
1.1e+00
cases:0.92%
controls:1.05%
cases:0.29%
controls:0.26%
—
—
—
—
—
—
cases:0.41%
controls:0.17%
cases:1.49%
controls:0.49%
16
181
1714
17072
5
44
1725
17209
—
—
—
7
29
1685
16839
22
71
1459
14432
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
4.6e-01
—
—
—
-1.0e+50
1.2e+00
1.1e+00
cases:0.52%
controls:0.33%
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.30%
controls:0.09%
cases:0.88%
controls:0.29%
9
57
1721
17196
—
—
—
0
6
1729
17225
5
15
1687
16853
13
42
1468
14461
Cervicalgia
M54.2 [45591867]
1.1e+00
7.6e-01
-1.0e+50
—
-1.0e+50
6.5e-01
3.1e-02
cases:1.45%
controls:0.48%
cases:0.35%
controls:0.16%
cases:0.00%
controls:0.03%
—
—
cases:0.00%
controls:0.03%
cases:0.30%
controls:0.15%
cases:0.81%
controls:0.79%
25
83
1705
17170
6
28
1724
17225
0
5
1730
17248
—
0
6
1729
17225
5
26
1687
16842
12
114
1469
14389
insulin degludec; parenteral
A10AE06 [43534747]
1.1e+00
5.7e-01
—
—
—
4.0e-01
6.2e-01
cases:0.81%
controls:0.28%
cases:0.64%
controls:0.36%
—
—
—
—
—
—
cases:0.65%
controls:0.44%
cases:1.15%
controls:0.62%
14
48
1716
17205
11
62
1719
17191
—
—
—
11
74
1681
16794
17
90
1464
14413
Gas panel - Central venous blood
97535-9 [1616796]
4.9e-01
—
—
—
—
6.6e-01
1.1e+00
cases:0.40%
controls:0.25%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.18%
cases:1.08%
controls:0.37%
7
43
1723
17210
—
—
—
—
6
31
1686
16837
16
54
1465
14449
Tension-type headache
G44.2 [45581495]
2.0e-01
1.1e+00
—
—
—
1.4e-01
5.4e-01
cases:1.56%
controls:1.28%
cases:0.98%
controls:0.34%
—
—
—
—
—
—
cases:0.41%
controls:0.36%
cases:2.23%
controls:1.32%
27
221
1703
17032
17
59
1713
17194
—
—
—
7
61
1685
16807
33
191
1448
14312
Rotator cuff syndrome
M75.1 [45596678]
2.3e-01
5.9e-01
1.2e+00
—
1.0e+00
6.1e-01
4.4e-01
cases:3.87%
controls:3.11%
cases:2.08%
controls:1.17%
cases:0.52%
controls:0.16%
—
—
cases:0.46%
controls:0.16%
cases:2.13%
controls:1.16%
cases:5.81%
controls:3.83%
67
536
1663
16717
36
201
1694
17052
9
28
1721
17225
—
8
28
1721
17203
36
196
1656
16672
86
555
1395
13948
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
1.0e+00
—
—
—
—
-1.0e+50
7.6e-01
cases:0.87%
controls:0.31%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.68%
controls:0.32%
15
53
1715
17200
—
—
—
—
0
13
1692
16855
10
46
1471
14457
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
1.0e+00
6.3e-01
—
—
—
—
3.5e-01
cases:1.21%
controls:0.44%
cases:0.35%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.67%
21
76
1709
17177
6
32
1724
17221
—
—
—
—
14
97
1467
14406
ofloxacin
S01AE01 [43534856]
1.0e-01
7.8e-01
—
—
—
1.3e+00
1.0e+00
cases:0.52%
controls:0.47%
cases:0.29%
controls:0.13%
—
—
—
—
—
—
cases:0.47%
controls:0.13%
cases:1.28%
controls:0.48%
9
81
1721
17172
5
23
1725
17230
—
—
—
8
22
1684
16846
19
69
1462
14434
Throat symptom/complaint
R21 [2002000891]
3.2e-01
8.9e-01
—
—
-1.0e+50
1.0e+00
1.3e-01
cases:2.43%
controls:1.77%
cases:0.87%
controls:0.36%
—
—
—
—
cases:0.00%
controls:0.05%
cases:1.18%
controls:0.44%
cases:1.96%
controls:1.73%
42
306
1688
16947
15
62
1715
17191
—
—
0
9
1729
17222
20
74
1672
16794
29
251
1452
14252
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
8.8e-02
3.0e-01
—
—
—
7.2e-01
1.0e+00
cases:0.81%
controls:0.74%
cases:0.40%
controls:0.30%
—
—
—
—
—
—
cases:0.41%
controls:0.20%
cases:1.76%
controls:0.66%
14
128
1716
17125
7
52
1723
17201
—
—
—
7
34
1685
16834
26
95
1455
14408
prazosin; oral
C02CA01 [21600411]
8.2e-01
9.7e-01
-1.0e+50
—
—
9.2e-01
9.9e-01
cases:0.81%
controls:0.36%
cases:0.58%
controls:0.22%
cases:0.00%
controls:0.10%
—
—
—
—
cases:0.59%
controls:0.24%
cases:1.01%
controls:0.38%
14
62
1716
17191
10
38
1720
17215
0
17
1730
17236
—
—
10
40
1682
16828
15
55
1466
14448
Urinary tract ultrasound examination
KH1AE [2001306329]
9.8e-01
1.0e+00
—
—
—
—
9.0e-01
cases:0.92%
controls:0.35%
cases:0.40%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.41%
16
60
1714
17193
7
25
1723
17228
—
—
—
—
15
60
1466
14443
tibolone; oral
G03CX01 [21602536]
3.3e-01
5.5e-01
—
—
—
6.9e-01
9.8e-01
cases:1.10%
controls:0.79%
cases:0.75%
controls:0.43%
—
—
—
—
—
—
cases:0.77%
controls:0.39%
cases:1.42%
controls:0.54%
19
137
1711
17116
13
75
1717
17178
—
—
—
13
65
1679
16803
21
78
1460
14425
Restricted oral and dental health check by dental hygienist or dental assistant
SAB01 [2001310279]
9.8e-01
—
—
—
—
—
5.1e-01
cases:1.33%
controls:0.50%
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.53%
23
87
1707
17166
—
—
—
—
—
13
77
1468
14426
Bacteria identified in Urine by Culture
630-4 [3026008]
6.2e-02
3.1e-02
9.6e-01
—
-3.4e-03
2.0e-01
1.0e-01
cases:5.03%
controls:4.74%
cases:2.66%
controls:2.58%
cases:1.04%
controls:0.40%
—
—
cases:0.40%
controls:0.41%
cases:3.61%
controls:2.96%
cases:10.13%
controls:9.21%
87
818
1643
16435
46
445
1684
16808
18
69
1712
17184
—
7
70
1722
17161
61
500
1631
16368
150
1336
1331
13167
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
5.1e-01
6.9e-01
—
—
-1.0e+50
3.5e-01
9.3e-01
cases:0.58%
controls:0.35%
cases:0.35%
controls:0.17%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.30%
controls:0.21%
cases:1.15%
controls:0.46%
10
60
1720
17193
6
30
1724
17223
—
—
0
8
1729
17223
5
35
1687
16833
17
66
1464
14437
Multidisciplinary treatment meeting
WZC20 [2001310890]
-1.7e-01
—
—
—
—
1.0e+00
9.2e-01
cases:0.40%
controls:0.48%
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.11%
cases:1.22%
controls:0.49%
7
83
1723
17170
—
—
—
—
5
18
1687
16850
18
71
1463
14432
Chronic maxillary sinusitis
J32.0 [45586667]
5.1e-01
6.0e-01
—
—
—
5.1e-01
9.2e-01
cases:0.92%
controls:0.56%
cases:0.35%
controls:0.19%
—
—
—
—
—
—
cases:0.35%
controls:0.21%
cases:1.35%
controls:0.54%
16
96
1714
17157
6
33
1724
17220
—
—
—
6
36
1686
16832
20
79
1461
14424
12 lead EKG panel
34534-8 [3044889]
-2.9e-02
3.8e-02
4.2e-01
—
6.7e-01
2.1e-01
2.2e-01
cases:14.62%
controls:14.99%
cases:8.67%
controls:8.38%
cases:1.50%
controls:0.99%
—
—
cases:1.79%
controls:0.93%
cases:10.28%
controls:8.53%
cases:25.39%
controls:21.37%
253
2586
1477
14667
150
1445
1580
15808
26
171
1704
17082
—
31
160
1698
17071
174
1438
1518
15430
376
3100
1105
11403
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
8.9e-01
5.8e-01
—
—
—
8.5e-01
5.6e-01
cases:1.39%
controls:0.57%
cases:0.40%
controls:0.23%
—
—
—
—
—
—
cases:0.41%
controls:0.18%
cases:1.28%
controls:0.74%
24
99
1706
17154
7
39
1723
17214
—
—
—
7
30
1685
16838
19
107
1462
14396
Extensive body CT
JN4BD [2001310899]
4.2e-01
2.1e-01
—
—
—
2.4e-01
8.9e-01
cases:2.02%
controls:1.33%
cases:0.64%
controls:0.52%
—
—
—
—
—
—
cases:0.41%
controls:0.33%
cases:1.69%
controls:0.70%
35
230
1695
17023
11
89
1719
17164
—
—
—
7
55
1685
16813
25
102
1456
14401
Catheterisation of bladder
TKC20 [2001306020]
5.8e-01
2.2e-01
-1.0e+50
—
—
7.2e-01
8.7e-01
cases:1.04%
controls:0.59%
cases:0.29%
controls:0.23%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.53%
controls:0.26%
cases:1.62%
controls:0.68%
18
101
1712
17152
5
40
1725
17213
0
5
1730
17248
—
—
9
44
1683
16824
24
99
1457
14404
Periodontal treatment by dental hygienist, extensive
SDE03 [2001310351]
2.1e-01
4.0e-01
—
—
-1.0e+50
8.7e-01
3.3e-01
cases:3.47%
controls:2.83%
cases:0.87%
controls:0.59%
—
—
—
—
cases:0.00%
controls:0.05%
cases:1.24%
controls:0.52%
cases:2.90%
controls:2.10%
60
489
1670
16764
15
101
1715
17152
—
—
0
8
1729
17223
21
88
1671
16780
43
305
1438
14198
Ultrasound examination of mammary glands
HA1AE [2001303886]
1.5e-01
3.2e-01
—
—
—
2.4e-01
8.7e-01
cases:0.98%
controls:0.85%
cases:0.46%
controls:0.34%
—
—
—
—
—
—
cases:0.35%
controls:0.28%
cases:1.42%
controls:0.60%
17
146
1713
17107
8
58
1722
17195
—
—
—
6
47
1686
16821
21
87
1460
14416
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
3.1e-01
4.1e-01
—
—
—
—
8.5e-01
cases:1.10%
controls:0.81%
cases:0.29%
controls:0.19%
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.61%
19
139
1711
17114
5
33
1725
17220
—
—
—
—
21
89
1460
14414
Stomatognathic treatment, simple
SHA01 [2001310405]
4.5e-01
—
—
—
—
5.1e-01
8.2e-01
cases:1.21%
controls:0.78%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.21%
cases:1.82%
controls:0.81%
21
134
1709
17119
—
—
—
—
6
36
1686
16832
27
118
1454
14385
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
5.4e-01
4.8e-01
-1.0e+50
—
—
6.0e-01
8.2e-01
cases:1.85%
controls:1.09%
cases:1.21%
controls:0.75%
cases:0.00%
controls:0.10%
—
—
—
—
cases:1.18%
controls:0.65%
cases:4.05%
controls:1.83%
32
188
1698
17065
21
130
1709
17123
0
17
1730
17236
—
—
20
110
1672
16758
60
266
1421
14237
Diabetes insulin dependent
T89 [2002001130]
7.4e-01
9.0e-01
—
—
—
8.3e-01
7.9e-01
cases:1.04%
controls:0.50%
cases:0.87%
controls:0.35%
—
—
—
—
—
—
cases:0.95%
controls:0.41%
cases:1.69%
controls:0.77%
18
86
1712
17167
15
61
1715
17192
—
—
—
16
70
1676
16798
25
112
1456
14391
Other medical or dental certificate
WZA90 [2001310883]
1.4e-01
7.8e-01
—
—
-1.0e+50
5.6e-01
2.7e-01
cases:3.24%
controls:2.82%
cases:1.45%
controls:0.67%
—
—
—
—
cases:0.00%
controls:0.05%
cases:1.24%
controls:0.71%
cases:3.38%
controls:2.59%
56
486
1674
16767
25
115
1705
17138
—
—
0
9
1729
17222
21
120
1671
16748
50
375
1431
14128
other preparations, combinations; ointment
C05AX03 [21601631]
3.0e-01
2.0e-01
—
—
8.7e-01
6.8e-01
7.6e-01
cases:3.24%
controls:2.42%
cases:0.98%
controls:0.81%
—
—
—
—
cases:0.29%
controls:0.12%
cases:1.65%
controls:0.84%
cases:4.66%
controls:2.24%
56
417
1674
16836
17
139
1713
17114
—
—
5
21
1724
17210
28
142
1664
16726
69
325
1412
14178
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
7.6e-01
6.7e-02
-1.0e+50
—
—
1.7e-02
3.1e-01
cases:1.91%
controls:0.90%
cases:0.35%
controls:0.32%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.30%
controls:0.29%
cases:1.42%
controls:1.04%
33
156
1697
17097
6
56
1724
17197
0
5
1730
17248
—
—
5
49
1687
16819
21
151
1460
14352
Otolaryngology
4 [38004449]
3.1e-01
3.5e-01
-1.8e-01
—
-4.8e-02
2.0e-01
4.4e-01
cases:13.64%
controls:10.39%
cases:5.90%
controls:4.23%
cases:0.52%
controls:0.62%
—
—
cases:0.64%
controls:0.67%
cases:5.02%
controls:4.16%
cases:17.56%
controls:12.01%
236
1793
1494
15460
102
729
1628
16524
9
107
1721
17146
—
11
115
1718
17116
85
701
1607
16167
260
1742
1221
12761
Laceration/cut
S18 [2002000983]
3.8e-01
1.5e-01
-3.3e-01
-1.0e+50
3.5e-01
3.0e-01
3.7e-01
cases:10.12%
controls:7.15%
cases:3.29%
controls:2.85%
cases:0.29%
controls:0.40%
cases:0.00%
controls:0.04%
cases:0.40%
controls:0.28%
cases:3.61%
controls:2.70%
cases:12.96%
controls:9.30%
175
1234
1555
16019
57
492
1673
16761
5
69
1725
17184
0
7
1730
17246
7
49
1722
17182
61
455
1631
16413
192
1349
1289
13154
salmeterol and fluticasone
R03AK06 [21603280]
2.1e-01
2.8e-01
7.5e-01
—
3.0e-01
2.5e-01
3.7e-01
cases:3.70%
controls:3.01%
cases:3.06%
controls:2.32%
cases:1.62%
controls:0.77%
—
—
cases:0.98%
controls:0.73%
cases:3.13%
controls:2.47%
cases:5.06%
controls:3.55%
64
520
1666
16733
53
401
1677
16852
28
133
1702
17120
—
17
126
1712
17105
53
416
1639
16452
75
515
1406
13988
insulin lispro; parenteral
A10AD04 [21600732]
7.5e-01
7.3e-01
—
—
9.6e-01
6.3e-01
5.7e-01
cases:1.73%
controls:0.83%
cases:1.27%
controls:0.61%
—
—
—
—
cases:0.35%
controls:0.13%
cases:1.24%
controls:0.66%
cases:1.42%
controls:0.81%
30
143
1700
17110
22
106
1708
17147
—
—
6
23
1723
17208
21
112
1671
16756
21
117
1460
14386
insulin lispro; parenteral
A10AB04 [21600718]
7.3e-01
7.0e-01
—
—
9.1e-01
6.0e-01
5.5e-01
cases:1.73%
controls:0.84%
cases:1.27%
controls:0.64%
—
—
—
—
cases:0.35%
controls:0.14%
cases:1.24%
controls:0.69%
cases:1.42%
controls:0.82%
30
145
1700
17108
22
110
1708
17143
—
—
6
24
1723
17207
21
116
1671
16752
21
119
1460
14384
insulin lispro; parenteral
A10AC04 [21600726]
7.3e-01
7.0e-01
—
—
9.1e-01
6.0e-01
5.5e-01
cases:1.73%
controls:0.84%
cases:1.27%
controls:0.64%
—
—
—
—
cases:0.35%
controls:0.14%
cases:1.24%
controls:0.69%
cases:1.42%
controls:0.82%
30
145
1700
17108
22
110
1708
17143
—
—
6
24
1723
17207
21
116
1671
16752
21
119
1460
14384
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
3.9e-01
3.3e-01
—
—
—
8.1e-01
7.2e-01
cases:0.81%
controls:0.55%
cases:0.40%
controls:0.29%
—
—
—
—
—
—
cases:0.41%
controls:0.18%
cases:1.82%
controls:0.90%
14
95
1716
17158
7
50
1723
17203
—
—
—
7
31
1685
16837
27
130
1454
14373
Dizziness and giddiness
R42 [45568132]
1.1e-01
7.0e-01
1.3e+00
—
1.2e+00
2.2e-01
2.2e-01
cases:3.70%
controls:3.33%
cases:2.31%
controls:1.16%
cases:0.46%
controls:0.13%
—
—
cases:0.29%
controls:0.09%
cases:1.48%
controls:1.19%
cases:5.06%
controls:4.09%
64
574
1666
16679
40
200
1690
17053
8
22
1722
17231
—
5
15
1724
17216
25
201
1667
16667
75
593
1406
13910
Immunohistochemistry procedure
117617002 [4035726]
-2.9e-01
8.1e-02
—
—
—
1.2e-01
7.0e-01
cases:1.04%
controls:1.38%
cases:0.58%
controls:0.53%
—
—
—
—
—
—
cases:0.35%
controls:0.31%
cases:2.30%
controls:1.15%
18
238
1712
17015
10
92
1720
17161
—
—
—
6
53
1686
16815
34
167
1447
14336
Physical Medicine And Rehabilitation
25 [38004468]
3.2e-01
4.2e-01
7.2e-01
—
4.7e-01
3.6e-01
3.8e-01
cases:7.80%
controls:5.80%
cases:3.29%
controls:2.19%
cases:0.52%
controls:0.26%
—
—
cases:0.46%
controls:0.29%
cases:2.60%
controls:1.82%
cases:8.58%
controls:6.03%
135
1001
1595
16252
57
378
1673
16875
9
44
1721
17209
—
8
50
1721
17181
44
307
1648
16561
127
874
1354
13629
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
1.3e-03
-3.2e-02
—
—
—
4.2e-01
6.9e-01
cases:1.45%
controls:1.44%
cases:0.58%
controls:0.60%
—
—
—
—
—
—
cases:0.77%
controls:0.50%
cases:3.17%
controls:1.61%
25
249
1705
17004
10
103
1720
17150
—
—
—
13
85
1679
16783
47
234
1434
14269
EKG study
11524-6 [3013512]
-6.5e-02
5.1e-02
1.8e-01
—
9.0e-02
3.7e-01
3.1e-01
cases:5.72%
controls:6.09%
cases:4.05%
controls:3.85%
cases:0.52%
controls:0.43%
—
—
cases:0.52%
controls:0.48%
cases:5.85%
controls:4.10%
cases:13.84%
controls:10.55%
99
1050
1631
16203
70
665
1660
16588
9
75
1721
17178
—
9
82
1720
17149
99
691
1593
16177
205
1530
1276
12973
Hand/finger symptom/complaint
L12 [2002000636]
3.3e-01
3.6e-01
—
—
—
-3.0e-01
6.7e-01
cases:1.97%
controls:1.41%
cases:0.69%
controls:0.49%
—
—
—
—
—
—
cases:0.41%
controls:0.56%
cases:3.85%
controls:2.01%
34
244
1696
17009
12
84
1718
17169
—
—
—
7
94
1685
16774
57
291
1424
14212
Abdominal ultrasound examination
JN3AE [2001305555]
1.2e-01
2.9e-01
-1.0e+50
—
—
1.7e-01
6.6e-01
cases:1.45%
controls:1.28%
cases:0.64%
controls:0.48%
cases:0.00%
controls:0.05%
—
—
—
—
cases:0.53%
controls:0.45%
cases:2.63%
controls:1.37%
25
221
1705
17032
11
82
1719
17171
0
9
1730
17244
—
—
9
76
1683
16792
39
199
1442
14304
Ultrasound examination of lower leg veins
PH2AE [2001309451]
2.8e-01
—
—
—
—
-8.3e-02
6.5e-01
cases:1.56%
controls:1.19%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.39%
cases:2.57%
controls:1.35%
27
205
1703
17048
—
—
—
—
6
65
1686
16803
38
196
1443
14307
More than three and less than five hours
ZXE20 [2001311408]
6.5e-01
1.8e-01
-1.0e+50
—
—
1.4e-01
6.5e-01
cases:2.54%
controls:1.34%
cases:0.58%
controls:0.48%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.35%
controls:0.31%
cases:1.96%
controls:1.03%
44
232
1686
17021
10
83
1720
17170
0
11
1730
17242
—
—
6
52
1686
16816
29
150
1452
14353
Hip X-ray examination
NF1AA [2001307894]
6.4e-01
5.9e-01
-1.0e+50
—
—
1.9e-01
5.3e-01
cases:2.02%
controls:1.07%
cases:0.81%
controls:0.45%
cases:0.00%
controls:0.05%
—
—
—
—
cases:0.47%
controls:0.39%
cases:2.30%
controls:1.36%
35
185
1695
17068
14
78
1716
17175
0
8
1730
17245
—
—
8
66
1684
16802
34
197
1447
14306
Kuhnt-Junius degeneration
H35.30 [2000502314]
2.7e-01
2.5e-01
—
1.0e+50
—
9.4e-01
6.4e-01
cases:1.04%
controls:0.80%
cases:0.46%
controls:0.36%
—
—
cases:0.69%
controls:0.00%
—
—
cases:0.89%
controls:0.35%
cases:2.43%
controls:1.30%
18
138
1712
17115
8
62
1722
17191
—
12
0
1718
17253
—
15
59
1677
16809
36
188
1445
14315

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
564
4540
1.36
7.78
5.5
4.6
0.00
0.00
estimate
0.96
220
1552
57
257
2.26
7.50
3.9
2.9
4.46
4.32
e9/l
0.17
57
257
641
5293
1.33
7.36
2.3
2.2
146.71
212.25
u/l
2.95
588
4990
1403
12967
1.40
7.34
6.2
5.7
1.96
2.04
mu/l
1.07
1267
11744
265
1894
1.47
7.22
2.1
1.8
—
—
—
0
0
204
1389
1.53
7.03
4.6
4.0
1.23
1.23
mmol/l
0.00
177
1187
693
5859
1.30
6.50
5.5
4.6
0.62
0.49
estimate
0.08
207
1400
1278
11715
1.33
6.49
8.8
8.5
81.62
81.68
u/l
0.02
1203
11036
761
6519
1.29
6.44
5.0
4.4
59.89
84.67
ng/l
0.61
623
5106
831
7203
1.29
6.41
2.7
2.5
81.03
79.99
nmol/l
0.43
727
6321
983
8719
1.29
6.28
8.1
7.4
1.22
1.21
mmol/l
0.39
822
7513
633
5306
1.30
6.28
5.2
4.2
7.40
7.40
ph
0.48
473
3849
920
8098
1.28
6.22
18.9
18.6
1.30
1.34
inr
1.37
791
6791
1531
14476
1.43
6.10
26.7
24.2
4.01
4.00
mmol/l
0.91
1505
14162
62
315
2.00
6.08
4.3
2.8
61.05
58.97
%
0.71
62
315
1529
14456
1.43
6.07
26.4
24.0
139.52
139.57
mmol/l
0.27
1503
14162
904
7965
1.28
5.96
5.3
4.5
0.00
0.00
estimate
-0.00
238
1701
380
2987
1.35
5.89
1.3
1.3
1.77
1.43
u/ml
0.19
111
739
1144
10394
1.29
5.81
6.3
5.6
4933.23
2018.57
e6/l
0.26
13
169
911
8064
1.27
5.66
5.2
4.5
0.03
0.93
estimate
0.49
238
1772
891
7871
1.27
5.61
7.4
6.6
1.21
1.21
mmol/l
0.29
809
7217
917
8130
1.27
5.60
5.3
4.5
0.24
0.19
estimate
0.06
222
1661
1544
14667
1.42
5.55
29.0
26.3
82.77
81.31
umol/l
0.72
1522
14444
1472
13876
1.37
5.52
21.6
19.6
25.24
26.95
mg/l
1.11
1276
11762
654
5582
1.27
5.43
3.8
3.4
6.71
6.87
mmol/l
0.49
547
4607
16
33
4.88
5.43
1.7
1.5
—
—
—
0
0
168
1161
1.49
5.41
6.1
4.7
—
—
—
0
0
600
5070
1.28
5.40
3.5
2.6
72.63
77.09
u/l
0.08
553
4664
1191
10921
1.28
5.39
4.9
4.6
15.21
15.13
pmol/l
0.49
1072
9822
369
2923
1.33
5.39
5.1
4.9
—
—
—
0
0
864
7631
1.26
5.35
5.2
5.1
34.75
34.78
g/l
0.06
786
7106
419
3385
1.31
5.31
3.8
3.1
514.97
522.50
mosm/kgh2o
0.30
373
2948
740
6425
1.26
5.29
4.5
4.0
6.32
6.29
ph
0.27
399
3459
741
6438
1.26
5.26
13.7
12.5
0.00
0.00
e9/l
0.31
623
5174
657
5632
1.27
5.21
4.6
4.1
8.88
8.81
mg/mmol
0.02
399
3428
1549
14760
1.40
5.12
32.6
29.7
246.36
245.44
e9/l
0.21
1514
14382
1549
14761
1.40
5.11
32.5
29.6
91.69
91.72
fl
0.12
1527
14539
1549
14762
1.40
5.10
33.0
30.2
39.47
39.29
%
0.72
1526
14531
1549
14762
1.40
5.10
32.5
29.6
4.35
4.37
e12/l
0.62
1506
14333
1549
14762
1.40
5.10
32.4
29.5
30.34
30.37
pg
0.37
1528
14539
1518
14419
1.38
5.10
13.9
13.3
22.98
24.49
u/l
4.43
1465
13913
1549
14765
1.40
5.07
32.5
29.7
6.94
6.89
e9/l
0.38
1507
14331
1549
14766
1.40
5.06
32.8
29.9
131.01
131.54
g/l
0.70
1526
14552
1408
13235
1.31
5.01
8.0
7.3
41.44
40.26
mmol/mol
4.36
1283
12146
1040
9449
1.24
4.78
5.7
5.2
7.02
6.82
mmol/l
2.09
991
9035
639
5508
1.25
4.72
3.9
3.4
53.49
46.90
mg/l
0.30
391
3456
466
3875
1.28
4.66
3.7
2.8
4.32
5.52
e6/l
2.17
429
3529
1141
10489
1.25
4.65
6.1
5.2
—
2.21
—
0
17
670
5826
1.24
4.53
3.9
3.8
—
—
—
0
0
935
8455
1.22
4.27
6.1
6.6
11.11
12.16
umol/l
2.37
872
8056
64
374
1.74
4.16
1.7
1.9
10.33
12.87
mg/l
1.32
56
345
681
5976
1.23
4.13
3.1
3.3
1480.14
1678.63
ng/l
0.79
594
5209
873
7862
1.22
4.08
6.1
6.3
0.19
0.19
e9/l
0.07
749
6719
324
2619
1.29
4.01
1.9
2.0
30.03
29.72
s
0.22
314
2536
1186
11031
1.23
3.96
4.9
4.5
14.54
14.64
mm/h
0.07
1103
10204
428
3585
1.26
3.95
1.9
1.8
18731587.11
20365079.48
pmol/l
0.03
331
2907
79
496
1.62
3.95
1.4
1.5
—
—
—
0
0
1424
13533
1.27
3.81
6.0
5.7
6.21
6.06
mmol/l
2.75
1280
12127
551
4762
1.23
3.80
4.2
3.5
0.41
0.51
e6/l
0.56
438
3565
845
7630
1.21
3.71
6.1
6.1
0.04
0.04
e9/l
0.01
720
6418
403
3376
1.25
3.70
1.9
1.8
1332.42
1163.96
nmol/l
2.07
297
2526
195
1487
1.35
3.65
4.8
3.6
91.38
94.44
ng/l
0.20
162
1243
62
377
1.67
3.54
2.8
2.3
225.32
71.84
ug/min
0.65
38
220
11
26
4.25
3.50
6.2
4.2
—
—
—
0
0
622
5478
1.21
3.50
4.5
3.7
53.87
83.41
e6/l
0.69
500
4235
518
4481
1.22
3.50
4.1
3.5
2134.97
0.00
estimate
—
6
21
1434
13680
1.26
3.45
6.6
6.3
2.51
2.57
mmol/l
1.77
1301
12405
840
7614
1.20
3.45
6.1
6.1
0.62
0.61
e9/l
0.43
712
6396
339
2806
1.26
3.44
2.9
2.6
2.26
2.28
g/l
0.24
297
2569
70
447
1.59
3.31
3.3
2.7
1.77
1.73
mg/l
0.12
65
392
675
6015
1.20
3.31
3.5
3.6
2.35
2.36
mmol/l
0.56
608
5385
852
7757
1.19
3.27
6.1
6.1
1.81
1.87
e9/l
0.38
739
6682
180
1387
1.33
3.16
1.7
1.5
—
—
—
0
0
59
366
1.63
3.15
3.9
4.5
—
—
—
0
0
1339
12718
1.22
3.14
4.6
4.5
1.25
1.28
mmol/l
0.71
1194
11346
160
1216
1.35
3.09
1.8
1.5
—
—
—
0
0
41
232
1.79
3.05
1.8
1.3
—
—
—
0
0
55
339
1.64
3.03
4.9
5.3
5.10
5.09
kpa
0.04
55
333
55
339
1.64
3.03
4.9
5.3
2.20
2.84
mmol/l
0.99
41
239
55
339
1.64
3.03
4.9
5.3
8.49
8.39
kpa
0.18
55
333
466
4041
1.21
3.01
5.0
4.0
0.14
0.26
estimate
0.22
194
1338
203
1604
1.30
2.99
3.0
2.5
5.14
6.99
ug/l
1.54
168
1383
14
51
2.76
2.98
2.3
2.2
0.62
0.61
mmol/l
0.37
14
51
1387
13241
1.22
2.98
5.5
5.4
1.50
1.47
mmol/l
1.19
1255
11965
936
8643
1.18
2.91
8.6
9.6
4.47
4.24
e9/l
1.30
799
7426
22
102
2.17
2.87
1.1
1.2
—
—
—
0
0
1396
13355
1.22
2.83
5.7
5.4
4.47
4.50
mmol/l
0.57
1265
12157
22
103
2.15
2.81
2.3
2.4
51.06
54.29
iu/ml
—
7
19
310
2603
1.23
2.75
3.0
2.7
20.55
21.48
%
0.69
278
2402
48
294
1.65
2.73
7.1
1.4
0.97
0.85
nmol/l
0.49
37
239
351
2987
1.22
2.73
3.0
2.7
11.49
12.00
umol/l
0.75
313
2771
172
1348
1.31
2.71
4.2
4.6
1.88
0.11
%
0.57
34
362
80
553
1.47
2.69
4.4
4.3
7.40
7.41
ph
0.91
80
547
727
6608
1.17
2.67
3.4
3.1
141.83
138.40
ug/l
0.14
653
6045
36
205
1.77
2.66
1.8
1.3
197.00
167.61
au/ml
—
10
63
148
1140
1.33
2.64
4.5
6.8
24.31
24.53
mmol/l
0.27
138
1082
173
1362
1.30
2.64
3.9
4.3
0.10
0.10
%
0.03
40
396
214
1736
1.26
2.58
1.3
1.3
—
—
—
0
0
1165
11007
1.17
2.55
26.0
24.5
13.95
13.91
%
0.38
1146
10852
16
69
2.33
2.48
2.2
2.8
1565.00
1861.90
ml
0.71
16
58
670
6080
1.16
2.47
5.1
4.3
122.37
124.05
e6/l
0.01
514
4366
787
7231
1.16
2.46
3.0
2.9
—
—
estimate
—
0
0
523
4656
1.18
2.45
2.4
2.4
3.03
3.00
mg/l
0.11
453
3981
403
3513
1.19
2.42
5.4
4.8
1.02
1.02
kg/l
0.70
264
2364
774
7112
1.16
2.40
6.2
6.3
2.85
2.79
%
0.33
704
6610
221
1818
1.25
2.37
1.6
1.5
—
—
—
0
0
170
1363
1.27
2.28
3.9
4.1
0.86
0.64
%
0.50
43
438
630
5720
1.16
2.26
2.1
2.0
1.30
1.31
mmol/l
0.20
498
4705
22
113
1.96
2.25
1.0
1.1
—
—
—
0
0
773
7129
1.15
2.23
6.3
6.4
9.19
9.10
%
0.36
703
6625
581
5253
1.16
2.20
1.7
1.8
22.00
20.14
nmol/l
1.88
481
4346
590
5342
1.16
2.19
5.7
6.0
—
—
—
0
0
107
813
1.34
2.14
1.4
1.4
—
—
—
0
0
177
1439
1.26
2.13
4.0
4.2
1.52
0.87
%
0.84
44
473
48
315
1.54
2.12
1.4
1.3
20.64
60.75
e6/l
0.67
39
232
329
2849
1.19
2.12
3.0
3.0
0.81
0.81
mmol/l
0.34
301
2639
641
5854
1.15
2.09
2.3
2.3
—
—
—
0
0
48
317
1.53
2.07
1.5
1.3
221.83
627.98
e6/l
0.52
40
247
5
10
5.01
2.07
3.2
4.8
—
—
—
0
0
496
4451
1.16
2.06
6.5
5.9
2.57
4.26
ug/l
1.03
435
3967
186
1531
1.24
2.01
1.8
1.6
—
—
—
0
0
48
320
1.51
1.99
1.1
1.1
—
—
—
0
0
828
7713
1.14
1.99
2.3
2.3
98.29
94.92
pmol/l
1.06
411
3948
767
7112
1.14
1.97
6.4
6.4
0.67
0.66
%
0.21
698
6604
379
3347
1.17
1.93
1.6
1.7
1.34
1.50
mg/l
0.44
302
2637
8
186
0.43
1.93
1.4
1.7
—
—
—
0
0
564
5129
1.15
1.93
4.4
4.5
—
—
—
0
0
282
2431
1.19
1.92
2.4
2.1
—
—
—
0
0
255
2179
1.20
1.91
1.3
1.2
—
—
—
0
0
194
1615
1.23
1.90
2.2
2.8
66.16
66.03
g/l
0.09
173
1463
275
2368
1.19
1.90
7.9
5.4
1.06
1.03
mmol/l
0.79
252
2164
304
2641
1.18
1.89
1.5
1.5
2.41
2.59
g/l
0.97
184
1519
36
553
0.64
1.88
1.3
1.8
3.37
3.42
mmol/l
0.06
23
395
222
1880
1.21
1.84
1.3
1.3
540.00
543.45
titre
0.01
56
452
20
108
1.86
1.82
2.0
2.2
—
—
—
0
0
924
8713
1.13
1.75
3.3
3.3
54.89
54.96
u/l
0.01
835
7994
7
24
2.92
1.72
1.0
1.2
—
—
—
0
0
220
1875
1.20
1.71
3.6
3.2
4.83
4.75
e9/l
0.05
177
1565
103
1302
0.78
1.71
3.9
3.2
6.01
6.08
ph
0.40
76
937
103
809
1.29
1.68
3.0
3.2
4.36
4.37
pmol/l
0.04
88
708
30
188
1.61
1.66
1.2
1.5
72.64
62.10
%
0.70
14
127
71
530
1.35
1.65
1.8
1.9
20.70
21.07
s
0.31
66
487
225
1929
1.19
1.65
5.7
7.6
94.83
95.18
%
0.30
214
1859
209
1782
1.20
1.63
6.2
8.0
120.02
118.92
g/l
0.32
202
1732
70
525
1.35
1.59
1.5
1.4
256.32
278.37
ug/g
0.42
44
306
10
44
2.28
1.55
1.2
1.2
—
—
—
0
0
19
322
0.59
1.54
3.9
4.0
25.58
38.89
u/ml
0.68
19
315
0
44
0.00
1.51
0.0
1.2
—
63.25
—
0
34
104
833
1.26
1.48
3.2
4.0
41.31
101.38
u/ml
2.53
97
805
171
1445
1.20
1.48
2.2
2.1
382.70
384.58
nmol/l
0.04
155
1326
123
1006
1.24
1.47
3.3
2.4
0.66
0.61
%
0.84
123
1001
87
683
1.29
1.46
2.8
3.6
35.12
65.62
mg/l
1.06
68
600
135
1118
1.22
1.44
5.6
7.4
25.20
24.96
mmol/l
0.26
135
1111
87
685
1.28
1.43
2.8
3.6
45.63
135.66
mg/l
0.61
68
599
448
4086
1.13
1.43
2.8
2.9
344.90
352.98
umol/l
0.77
375
3512
23
141
1.64
1.42
1.3
1.4
16.51
28.86
%
—
10
95
48
654
0.73
1.39
1.5
1.3
—
—
—
0
0
27
174
1.56
1.37
1.6
2.3
—
—
—
0
0
141
1180
1.21
1.37
3.1
3.9
5.20
5.18
kpa
0.12
133
1126
101
1240
0.80
1.35
1.7
1.6
—
—
—
0
0
411
3743
1.13
1.34
3.1
3.1
2.47
2.47
mmol/l
0.04
370
3346
138
1155
1.21
1.34
3.1
3.9
7.41
7.42
ph
0.64
118
973
61
464
1.33
1.31
12.9
12.2
—
—
—
0
0
283
2521
1.15
1.30
1.3
1.3
31.35
38.69
iu/ml
0.66
85
797
765
7221
1.10
1.29
6.4
6.4
25.81
26.15
%
0.36
704
6800
10
48
2.09
1.27
1.2
1.3
—
—
—
0
0
87
699
1.26
1.25
1.4
1.3
—
—
—
0
0
41
295
1.40
1.25
1.7
1.8
3.85
4.73
mmol/24h
1.45
34
249
6
25
2.40
1.24
1.0
1.0
—
—
—
0
0
42
304
1.39
1.24
1.2
1.1
21.16
8.02
eliau/ml
—
5
24
166
1436
1.17
1.15
1.4
1.4
—
—
—
0
0
121
1018
1.20
1.14
3.3
2.4
1.25
1.13
%
0.78
121
1010
8
40
2.00
1.12
3.4
2.0
9.63
10.19
%
—
8
32
78
630
1.25
1.10
3.4
4.1
24.73
25.07
mmol/l
0.43
68
570
14
81
1.73
1.09
8.8
6.4
5.60
35.21
ug/l
—
9
48
514
4796
1.10
1.07
2.9
3.2
30.97
34.57
u/l
1.32
475
4514
241
2156
1.14
1.06
6.0
7.3
0.97
1.01
mmol/l
0.04
194
1782
565
5300
1.10
1.05
2.5
2.6
—
—
—
0
0
38
280
1.36
1.04
1.3
1.2
—
—
—
0
0
38
280
1.36
1.04
1.4
1.2
—
—
—
0
0
127
1085
1.18
1.04
1.3
1.2
—
—
—
0
0
5
22
2.28
1.03
1.2
1.1
18.80
154.76
ng/l
—
5
14
184
1623
1.15
1.01
3.9
2.8
4.47
4.41
kpa
0.16
178
1582
209
1863
1.14
0.99
4.5
3.4
1.73
1.94
mmol/l
0.34
187
1617
242
2179
1.13
0.98
6.1
7.3
5.05
5.11
kpa
0.43
230
2081
0
30
0.00
0.97
0.0
2.5
—
39.68
—
0
23
0
30
0.00
0.97
0.0
7.3
—
5.25
—
0
30
242
2180
1.13
0.97
6.1
7.3
12.03
11.94
kpa
0.09
232
2083
18
116
1.56
0.96
1.3
1.3
—
—
—
0
0
22
149
1.48
0.95
1.1
1.2
2.62
4.74
u/ml
0.82
13
78
19
125
1.53
0.94
1.7
1.4
2.61
3.01
g/l
0.77
13
92
19
125
1.53
0.94
1.7
1.4
0.32
0.46
g/l
1.91
13
91
19
125
1.53
0.94
1.7
1.4
5.01
7.08
g/l
2.84
13
90
103
873
1.19
0.94
5.2
3.2
25.59
25.38
mmol/l
0.27
97
848
240
2168
1.12
0.92
6.1
7.3
7.42
7.42
ph
0.19
136
1186
404
3756
1.10
0.91
1.4
1.3
—
—
—
0
0
29
210
1.39
0.90
1.4
1.1
373.86
294.99
u/ml
0.52
21
111
37
281
1.32
0.87
1.7
2.0
0.78
0.89
%
0.83
24
201
41
526
0.77
0.87
4.8
3.5
0.75
0.82
nmol/l
0.74
35
432
55
441
1.26
0.86
1.5
2.3
129.67
127.04
g/l
0.31
45
344
13
201
0.64
0.81
1.2
1.2
1.54
1.56
g/l
0.09
13
201
212
1919
1.12
0.81
4.6
3.4
5.86
5.83
kpa
0.16
207
1872
181
1623
1.13
0.81
2.0
2.2
162.78
148.09
ug/g
0.18
144
1278
81
683
1.19
0.81
2.9
2.7
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
183
1645
1.13
0.79
9.4
6.4
10.99
10.80
mmol/l
0.14
175
1567
0
25
0.00
0.79
0.0
2.5
—
1.74
—
0
25
738
7074
1.07
0.78
6.2
6.3
58.86
58.48
%
0.40
686
6699
19
131
1.46
0.78
1.3
1.2
—
—
—
0
0
488
4607
1.08
0.78
6.7
6.6
—
—
—
0
0
51
412
1.24
0.77
1.4
1.3
—
—
—
0
0
15
222
0.67
0.77
1.3
1.2
0.73
0.92
g/l
3.34
15
222
71
595
1.20
0.76
2.6
3.0
3601.13
375.04
mg/l
0.51
24
218
74
623
1.20
0.76
2.9
3.3
2.29
4.71
ratio
0.77
43
372
9
54
1.67
0.74
1.1
1.0
1510.22
1557.59
miu/ml
—
9
54
5
25
2.00
0.72
2.0
1.2
19.32
31.99
mg/l
—
5
20
48
389
1.24
0.72
1.2
1.3
55.58
58.95
mmol/l
0.29
38
314
366
3431
1.08
0.70
4.5
4.4
243.45
296.59
ng/l
0.22
314
2933
177
1602
1.12
0.70
8.0
7.8
—
—
—
0
0
18
127
1.42
0.68
1.8
1.4
—
—
—
0
0
7
118
0.59
0.68
1.0
1.3
—
—
—
0
0
5
28
1.79
0.66
1.4
1.5
—
—
—
0
0
83
717
1.17
0.66
1.4
1.3
—
—
—
0
0
26
197
1.32
0.66
2.6
2.4
0.80
1.16
g/24h
0.61
15
107
12
78
1.54
0.65
1.2
1.4
—
—
—
0
0
256
2372
1.09
0.65
1.4
1.3
15.75
13.88
u/ml
0.15
96
810
28
360
0.77
0.64
4.0
4.0
30.54
26.84
mg/l
0.24
19
262
16
112
1.43
0.63
2.2
1.7
101.01
96.21
ng/l
0.07
16
112
211
1942
1.10
0.62
4.7
3.4
7.37
7.38
ph
0.65
116
1138
106
938
1.14
0.62
2.6
2.5
—
—
—
0
0
18
130
1.39
0.61
1.2
1.2
331.08
325.38
nmol/l
—
10
108
8
50
1.60
0.61
1.9
2.3
—
—
—
0
0
27
209
1.30
0.60
1.1
1.1
6.86
121.11
iu/ml
—
7
31
15
105
1.43
0.60
1.4
1.3
1.93
1.37
u/ml
—
8
60
48
400
1.21
0.58
1.1
1.2
—
990.83
—
0
12
7
114
0.61
0.58
1.7
1.8
—
—
—
0
0
8
54
1.48
0.57
1.0
1.4
133.75
166.48
mmol/24h
—
8
54
189
1741
1.10
0.56
4.8
4.6
7.35
7.36
ph
0.33
132
1227
25
194
1.29
0.56
1.6
2.1
—
—
—
0
0
16
116
1.38
0.54
2.4
2.6
—
—
—
0
0
151
1381
1.10
0.53
3.9
2.5
0.46
0.57
e6/l
0.25
141
1328
6
40
1.50
0.51
3.7
2.0
30.50
27.91
%
—
6
34
131
1192
1.11
0.51
4.4
2.9
124.56
126.47
g/l
0.38
124
1160
6
41
1.46
0.50
1.3
1.2
—
—
—
0
0
16
213
0.75
0.50
1.4
1.6
—
—
—
0
0
319
3021
1.07
0.49
3.5
3.2
1.43
1.34
e6/l
0.09
191
1640
10
68
1.47
0.47
1.2
1.2
—
—
—
0
0
86
770
1.12
0.46
1.2
1.2
120.03
123.29
u/ml
0.03
23
282
30
246
1.22
0.45
1.1
1.2
—
—
—
0
0
8
121
0.66
0.45
1.5
2.2
7.79
8.52
mmol/l
—
8
121
23
183
1.26
0.45
1.4
1.3
—
—
nmol/l
—
0
0
90
810
1.12
0.44
3.3
3.9
—
—
—
0
0
10
69
1.45
0.44
1.0
1.1
—
9.75
—
0
15
293
2781
1.06
0.43
3.6
3.3
1.83
2.64
e6/l
1.51
158
1392
27
221
1.23
0.42
2.9
1.7
0.66
0.87
g/l
0.40
20
175
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
30.23
—
0
17
17
132
1.29
0.40
2.4
3.1
20.43
22.59
mg/l
0.05
12
99
237
2241
1.07
0.40
2.3
2.5
1.80
1.84
%
0.27
206
1975
434
4177
1.05
0.40
3.9
3.6
—
—
—
0
0
7
104
0.67
0.39
1.1
1.1
—
—
—
0
0
5
35
1.43
0.39
1.4
1.5
—
—
—
0
0
9
68
1.33
0.37
1.1
2.6
551.00
1512.46
u/ml
—
9
68
11
147
0.75
0.37
1.2
1.1
0.18
0.99
u/ml
—
6
80
9
69
1.31
0.37
1.3
1.6
262.11
321.88
mu/l
—
9
50
6
42
1.43
0.35
1.2
1.2
—
—
—
0
0
14
108
1.30
0.35
1.4
1.5
1960.00
1822.52
ml
0.34
14
103
18
144
1.25
0.35
1.2
1.2
9.54
10.75
u/l
0.33
13
132
53
471
1.13
0.34
5.6
4.8
—
—
—
0
0
185
1746
1.07
0.34
2.2
2.6
67.31
69.44
e9/l
0.39
141
1291
26
218
1.20
0.34
1.5
1.8
175.96
201.36
pmol/l
0.70
26
203
29
246
1.18
0.34
2.7
2.8
—
—
—
0
0
28
237
1.18
0.33
1.3
1.4
61935.62
52667.71
e6/l
0.12
16
131
16
127
1.26
0.33
1.3
1.1
13.00
2.87
eliau/ml
—
8
38
38
435
0.87
0.33
1.3
1.2
—
—
—
0
0
6
87
0.69
0.33
1.0
1.2
142.67
131.89
nmol/l
—
6
87
171
1614
1.07
0.32
2.2
2.2
0.00
0.01
estimate
0.50
39
292
6
47
1.28
0.32
2.0
1.9
—
—
—
0
0
47
418
1.13
0.31
1.1
1.1
—
—
—
0
0
8
107
0.75
0.29
3.0
1.8
—
—
—
0
0
18
216
0.83
0.28
1.1
1.1
—
—
—
0
0
90
835
1.08
0.28
2.5
2.1
—
—
—
0
0
22
257
0.85
0.26
2.2
2.7
—
—
—
0
0
11
86
1.28
0.26
1.5
1.7
—
—
—
0
0
31
272
1.14
0.26
1.4
1.8
48.00
41.75
nmol/l
0.57
31
257
41
367
1.12
0.26
3.7
8.3
11.71
11.00
mmol/l
0.60
35
325
41
367
1.12
0.26
3.7
8.3
105.57
105.24
mmol/l
0.17
35
325
110
1034
1.07
0.25
8.3
9.9
15.61
15.59
%
0.03
105
990
19
224
0.85
0.25
1.4
1.5
—
—
—
0
0
9
76
1.19
0.24
1.2
2.1
—
46.34
—
0
5
188
1802
1.05
0.23
2.6
2.6
6.86
9.19
umol/l
0.89
156
1601
34
380
0.89
0.23
1.1
2.6
31.89
32.63
umol/l
0.06
28
329
207
1989
1.05
0.23
3.6
4.1
11.78
19.49
ug/l
0.54
168
1641
25
218
1.15
0.23
1.4
1.4
—
—
—
0
0
94
883
1.07
0.23
1.9
2.4
12.10
12.55
nmol/l
0.17
82
781
269
2601
1.04
0.23
3.6
3.5
0.75
0.80
ug/l
0.45
197
1792
14
168
0.83
0.22
1.1
1.2
—
—
—
0
0
85
796
1.07
0.22
2.2
2.2
0.00
1.14
estimate
0.50
27
221
7
95
0.74
0.22
1.1
1.1
—
—
—
0
0
12
146
0.82
0.22
2.0
2.3
0.86
1.70
u/field
—
7
73
63
584
1.08
0.22
1.6
1.7
6.87
7.12
iu/ml
0.02
12
142
57
526
1.09
0.22
3.7
7.1
1.26
1.35
mmol/l
0.49
47
460
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
29.60
—
0
5
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
27
239
1.13
0.21
1.3
1.3
42.58
31.03
iu/l
0.71
18
202
20
173
1.16
0.21
1.1
1.5
20.11
31.81
ng/l
0.85
20
173
53
489
1.09
0.20
1.5
1.6
17.52
18.21
u/ml
0.04
12
78
0
14
0.00
0.20
0.0
1.0
—
77.71
—
0
14
84
791
1.07
0.20
1.4
2.0
1.17
2.03
ug/l
0.63
67
685
9
111
0.81
0.20
1.1
1.0
289.67
295.07
mg/l
—
9
97
6
49
1.23
0.20
1.3
1.1
—
—
—
0
0
6
49
1.23
0.20
1.3
1.1
—
—
—
0
0
16
137
1.17
0.18
1.1
1.5
—
—
—
0
0
13
109
1.19
0.18
4.3
3.0
—
—
—
0
0
22
194
1.14
0.18
1.1
1.1
—
—
—
0
0
7
60
1.17
0.17
1.1
1.3
9.71
24.21
%
—
7
55
165
1591
1.04
0.17
3.1
3.1
228.59
235.15
ng/l
0.07
152
1465
16
184
0.87
0.17
2.8
3.1
14.45
11.28
index
0.88
11
97
71
670
1.06
0.17
1.4
1.5
—
22.78
—
0
16
10
120
0.83
0.16
1.2
1.0
3.03
2.53
u/ml
—
5
51
18
204
0.88
0.16
1.3
1.3
—
—
—
0
0
11
130
0.85
0.16
1.5
1.1
107.45
103.16
pmol/l
0.10
11
130
9
82
1.10
0.15
1.3
1.4
—
—
—
0
0
19
212
0.90
0.14
2.5
2.7
—
—
—
0
0
31
286
1.09
0.13
3.1
3.9
1.28
1.49
%
0.14
25
252
13
113
1.15
0.13
2.0
2.6
15.38
16.09
%
0.27
13
113
9
108
0.83
0.13
1.0
1.1
—
11.18
—
0
21
18
161
1.12
0.13
1.2
1.4
—
—
—
0
0
33
306
1.08
0.13
1.2
1.2
—
—
—
0
0
14
123
1.14
0.12
1.1
1.1
—
—
—
0
0
38
356
1.07
0.12
1.6
1.8
3.27
20.11
iu/l
0.51
14
140
16
143
1.12
0.11
1.1
1.5
—
—
—
0
0
175
1707
1.03
0.11
1.8
2.2
0.20
0.20
g/l
0.36
162
1580
14
124
1.13
0.11
1.1
1.1
—
—
—
0
0
153
1571
0.97
0.11
3.6
2.4
44.93
35.59
u/l
0.73
120
1312
43
454
0.95
0.10
1.5
1.6
0.43
0.33
mg/l
0.34
19
198
14
125
1.12
0.10
1.0
1.2
—
—
—
0
0
10
87
1.15
0.09
1.0
1.0
—
—
—
0
0
16
145
1.10
0.09
1.1
1.5
—
—
—
0
0
16
145
1.10
0.09
1.1
1.5
—
—
—
0
0
11
97
1.13
0.09
2.3
3.0
1.00
0.92
index
0.16
11
97
18
165
1.09
0.08
1.0
1.1
—
—
—
0
0
42
440
0.95
0.08
1.0
1.3
—
22.04
—
0
8
18
195
0.92
0.08
2.1
3.5
52.35
57.78
%
0.40
13
167
94
915
1.03
0.07
1.3
1.8
1.50
1.55
g/l
0.23
81
798
6
70
0.86
0.07
2.3
4.3
—
—
—
0
0
69
712
0.97
0.07
2.4
2.6
9.98
10.37
g/l
0.37
62
621
129
1263
1.02
0.07
1.5
1.5
—
—
—
0
0
8
78
1.03
0.07
1.0
1.0
—
—
—
0
0
7
80
0.87
0.07
1.0
1.1
—
—
—
0
0
7
82
0.85
0.07
1.6
1.3
11.19
22.50
umol/l
—
7
75
22
206
1.07
0.07
1.0
1.0
—
—
—
0
0
9
101
0.89
0.06
4.0
1.8
44.24
38.58
%
—
9
101
18
193
0.93
0.06
1.1
1.2
—
—
—
0
0
96
982
0.98
0.06
1.2
1.3
—
—
—
0
0
19
203
0.94
0.06
1.5
1.4
—
—
—
0
0
19
203
0.94
0.06
1.5
1.4
—
—
—
0
0
19
203
0.94
0.06
1.5
1.4
—
—
—
0
0
19
203
0.94
0.06
1.5
1.4
—
—
—
0
0
42
436
0.96
0.06
1.3
1.6
—
—
—
0
0
44
456
0.96
0.06
1.5
1.6
16173.21
16131.54
e6/l
0.00
28
317
87
851
1.02
0.05
3.7
5.4
1.51
1.51
%
0.04
77
800
18
192
0.94
0.05
1.5
1.2
—
—
—
0
0
17
159
1.07
0.05
1.2
1.2
—
—
—
0
0
17
159
1.07
0.05
2.1
2.3
1329.12
884.89
mg
0.28
17
159
48
495
0.97
0.05
4.0
3.4
1.84
2.09
index
0.14
31
248
414
4111
1.01
0.05
4.3
4.2
87.88
85.84
%
0.89
407
4026
1089
10912
0.99
0.03
29.2
26.0
330.08
330.69
g/l
1.47
1078
10827
91
922
0.99
0.02
1.7
1.8
1.24
1.45
g/l
0.43
84
835
204
2027
1.01
0.02
1.3
1.3
—
—
—
0
0
15
143
1.05
0.01
1.4
1.2
—
—
—
0
0
15
143
1.05
0.01
1.2
1.5
—
—
—
0
0
414
4150
1.00
0.01
3.8
3.5
0.00
0.06
1.92
13
154
34
346
0.98
0.00
2.0
1.7
—
—
—
0
0
58
575
1.01
0.00
1.6
1.2
—
—
—
0
0
77
775
0.99
0.00
3.8
5.7
0.88
0.86
%
0.16
68
728
15
152
0.99
0.00
1.4
1.2
—
—
—
0
0
14
138
1.01
0.00
1.2
1.1
—
—
—
0
0
21
208
1.01
0.00
1.0
1.3
22.86
10.28
u/l
0.77
12
168
14
137
1.02
0.00
1.2
1.2
—
—
—
0
0
33
327
1.01
0.00
1.3
1.2
—
—
—
0
0
70
700
1.00
-0.00
2.3
3.3
82.53
2305.78
u/ml
0.93
54
608
0
5
0.00
-0.00
0.0
1.2
—
160.00
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
93
0.97
-0.00
1.2
1.7
124.33
85.43
umol/l
—
9
93
0
5
0.00
-0.00
0.0
1.8
—
351.00
—
0
5
9
90
1.00
-0.00
3.3
1.8
15.33
16.32
%
—
9
84
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
2.38
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
0.05
—
0
5
0
6
0.00
-0.00
0.0
4.0
—
10.83
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
0.16
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
95
0.95
-0.00
1.6
1.5
12.89
15.28
umol/l
—
9
87
203
2030
1.00
-0.00
5.4
5.3
34.24
33.43
%
0.42
131
1263
7
78
0.90
-0.00
2.1
4.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
5
52
0.96
-0.00
1.6
1.8
0.00
0.00
estimate
—
5
52
5
52
0.96
-0.00
1.2
1.3
—
—
—
0
0
5
56
0.89
-0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.2
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
32.67
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
4.18
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint H7_GLAUCCLOSEPRIM and mortality.

Females

Parameter HR [95% CI] p-value
H7_GLAUCCLOSEPRIM 1.071 [0.99, 1.16] 0.085
Birth year 0.992 [0.98, 1.0] 0.045

During the follow-up period (1.1.1998 — 31.12.2019), 2692 out of 7308 females with H7_GLAUCCLOSEPRIM died.

Males

Parameter HR [95% CI] p-value
H7_GLAUCCLOSEPRIM 1.093 [0.98, 1.22] 0.115
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 1312 out of 3811 males with H7_GLAUCCLOSEPRIM died.

Mortality risk

Mortality risk for people of age

years, who have H7_GLAUCCLOSEPRIM.

N-year risk Females Males
1 0.064% 0.193%
5 0.526% 1.222%
10 1.319% 3.23%
15 2.475% 5.968%
20 4.646% 9.811%

Relationships between endpoints

↥

Index endpoint: H7_GLAUCCLOSEPRIM – Primary angle-closure glaucoma

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data